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Do not go gentle into that good night, 
Old age should burn and rave at close of day; 
Rage, rage against the dying of the light. 
 
 
Dylan Thomas – In Country Sleep, And Other Poems (1952) 
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Background 
Stroke is an important cause of both death and physical and cognitive impairments. It has a 
sudden and often devastating impact on the patient and his family. Stroke poses a significant 
burden on healthcare and society, and is a preventable and treatable condition. The clinical 
presentation of stroke varies from mild neurological symptoms to syndromes of multiple and 
severe neurological deficits. About half of the patients survive with physical or cognitive 
impairments, which often lead to limitations in daily activities.1,2 Consequently, the identification 
of patients who may benefit from early interventions - which are more effective shortly after the 
symptomatic event - is needed. 
 
Definition and types of stroke  
There are three pathological types of stroke: ischemic stroke, intracerebral hemorrhage, and 
subarachnoid hemorrhage. In the United States, the distribution of all strokes due to ischemia, 
intracerebral hemorrhage and subarachnoid hemorrhage is 87%, 10%, and 3%, respectively.3 
In Europe, the distribution of pathological stroke subtypes is 81.7% ischemic stroke, 12.4% 
intracerebral hemorrhage and 2.9% subarachnoid hemorrhage with 3.0% of the strokes 
undefined.4 However, the worldwide relative frequency of ischemic stroke is 68%, with a higher 
proportion of hemorrhagic stroke of 32%.5  
The World Health Organization (WHO) defines stroke as a syndrome of rapidly developing 
clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 
hours or longer or leading to death, with no apparent cause other than of vascular origin. A 
transient ischemic attack (TIA) is defined as a brief episode of neurologic dysfunction resulting 
from focal temporary cerebral ischemia not associated with cerebral infarction. However, these 
classic definitions are mainly based on clinical criteria and do not account for advances in 
vascular neurology and neuroimaging. Therefore, the American Heart Association/American 
Stroke Association published a scientific statement in 2009 redefining TIA as “a transient 
episode of neurological dysfunction caused by focal brain, spinal cord or retinal ischemia 
without acute infarction.6 In 2013, the Stroke Council of the American Heart 
Association/American Stroke Association redefined ischemic stroke as an episode of 
neurological dysfunction caused by focal cerebral, spinal, or retinal infarction, based on 1) 
pathological, imaging, or other objective evidence of cerebral, spinal cord, or retinal focal 
ischemic injury in a defined vascular distribution; or 2) clinical evidence of cerebral, spinal cord, 
or retinal focal ischemic injury based on symptoms persisting ≥24 hours or until death, and 
other etiologies excluded.7 For the studies in this thesis, TIA was defined clinically, as a 
sudden, focal neurological deficit presumed to be of vascular origin and confined to an area of 
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the brain perfused by a specific artery that lasted less than 24 hours. In addition, no relevant 
infarct (one that explains the deficit) should be present on the CT scan. Ischemic stroke was 
defined as a sudden focal neurologic deficit which lasted more than 24 hours or which was 
accompanied by a relevant infarct on the CT scan.  
 
Epidemiology and burden of disease 
Approximately 16 million first-ever strokes occur worldwide each year, leading to a total of 5.7 
million deaths.8 As a consequence, stroke is considered the second most frequent cause of 
mortality, and the third most common cause of disability.5,9 According to the Hartstichting 
 (Dutch Heart Foundation), the non-standardized incidence of hospitalization due to ischemic 
stroke in the Netherlands in 2018 was 173 per 100,000 inhabitants.10 The ischemic stroke-
related mortality in the Netherlands in 2018 was 32 per 100,000 inhabitants. Overall, stroke-
related mortality is decreasing. However, the absolute number of patients with stroke, stroke 
survivors and the worldwide burden of stroke-associated disability is increasing.11 
In terms of costs for society, stroke constitutes a considerable burden.12 Within the European 
Union €18.5 billion is spent each year on the direct costs of medical care for stroke patients. 
In addition, an indirect cost of €8.5 billion results from loss of productivity as a consequence of 
a stroke morbidity and mortality.13,14 A review of stroke cost studies demonstrated that an 
average 0.27% of gross domestic product was spent on stroke care by national healthcare 
systems, and that stroke care comprised approximately 3% of total health expenditure.12 
Strong motive therefore exists for better understanding of stroke pathophysiology, thereby 
striving to improved treatment and stroke prevention. 
 
Causes of ischemic stroke and transient ischemic attack 
Common causes of ischemic stroke as well as TIA comprise thrombosis, embolism, and local 
or systemic hypoperfusion. In addition, various rare causes of cerebral ischemia exist which 
include several blood disorders associated with increased blood coagulability.  
Cerebral ischemia due to thrombosis can be categorized into either large vessel disease or 
small vessel disease. Differentiation between these two subtypes is important because the 
cause, resulting disability, mortality and potential treatments may differ.  
In large vessel disease, pathological lesions in large extracranial and intracranial arteries may 
result in ischemic symptoms. Common pathological lesions in extracranial arteries include 
atherosclerosis, dissection and vasculopathies such as fibromuscular dysplasia. In large 
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intracranial arteries, pathological lesions comprise atherosclerosis, dissection, arteritis or 
vasculitis, non-inflammatory vasculopathy, and flow restriction due to localized 
vasoconstriction. Atherosclerosis is by far the most common cause of large vessel disease in 
both extracranial and intracranial arteries. Atherosclerotic lesions are often accompanied by 
superimposed thrombi. 
Atherosclerotic lesions in large arteries may generate cerebral ischemia either by severely 
reducing blood flow distal of a local lesion, or by embolism of a fragment of thrombus migrating 
downstream to a more distant artery (artery-to-artery thromboembolism). Both processes may 
be present simultaneously, as severe stenosis creates a low flow environment distal to the 
lesion which promotes the formation of thrombus of which emboli can dislodge. At the same 
time the reduced blood flow caused by the vascular obstruction makes the intracranial 
circulation less capable in washing out and clearing these thromboemboli.15  
In small vessel disease, obstruction of the deep penetrating arteries that arise from the distal 
vertebral artery, the basilar artery, the proximal middle cerebral artery, and the arteries of the 
circle of Willis leads to a lacunar infarction.16 A stroke due to obstruction of these vessels is 
referred to as a lacunar stroke, and often presents with distinct combination of symptoms. The 
smaller arteries and arterioles penetrate at a right angle to supply the deeper structures within 
the brain, such as the basal ganglia, internal capsule, thalamus, and the pons.16 Flow in these 
deep penetrating arteries may be obstructed due to lipohyalinosis and fibrinoid degeneration 
of the vessel wall, in which the media layer of the arterial wall becomes hypertrophic with 
depositions of lipid admixed with fibrinoid material. This process is most often related to 
hypertension. Other causes of small vessel disease are obstructions due to microatheromas 
in small penetrating arteries, and atherosclerotic plaques within the larger arteries that block 
or extend into the orifices of the deep penetrating branches.17  
In ischemic events due to embolism, particles of debris originating from sources elsewhere 
block arterial access to a particular brain region.18 Embolism from four different sources can 
be distinguished: cardiac embolism, artery to artery embolism, and embolism from an unknown 
source in which diagnostic tests for embolic sources are negative.19-22  
Systemic hypoperfusion reflects a general failure in systemic circulation. Consequently, 
reduced perfusion does not affect a specific region restricted to distribution of a single affected 
artery. The most severe ischemia often occurs in border zone or watershed regions located at 
the borders of the major supplying arteries of the brain, since these areas are most vulnerable 
to systemic hypoperfusion.  
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Atherosclerosis and vulnerable plaques 
Atherosclerosis is considered to be a dynamic process advancing in several phases starting 
with intima-media thickening, to proceed with fibrous cap atheroma (fibroatheroma) formation 
and thin-cap fibroatheroma formation. The process may ultimately lead to plaque rupture and 
ulceration.23 The resulting degree of arterial stenosis, as well as plaque phenotype are 
suggested to influence risk of TIA or stroke. Stenotic atherothrombotic lesions of more than 70 
percent at the carotid artery bifurcation are associated with embolic or low-flow TIA or ischemic 
stroke.24-27 A significant drop in pressure is observed distal to these stenotic lesions.28,29 In this 
situation of low and turbulent flow thrombus formation and subsequent embolism may occur.  
Between intima-media thickening and the development of more advanced fibroatheromas, 
pathologic intima-media thickening occurs which is characterized by the formation of 
extracellular lipid pools.23,30 In this stage necrosis within the plaque is still absent. The 
development of calcification may start, which is thought to arise from the demise of smooth 
muscle cells.31 Alternatively, progression to advanced fibroatheromas may start with the 
development of a fibrous cap atheroma, featuring a lipid-rich necrotic core and a cap of fibrous 
tissue.23,32 Fibrous cap atheroma progression may lead to a large plaque volume with a 
significant decrease in luminal diameter, especially after intra-plaque hemorrhage. This stage 
is succeeded by the thin-cap fibroatheroma, also designated as a vulnerable plaque. At this 
stage, lesions are distinguished by a large necrotic core of approximately 25% of the plaque 
volume and a thin fibrous cap of less than 65 µmin thickness. Typically, this thin cap is densely 
colonized by macrophages and T-lymphocytes, whereas smooth muscle cells are absent.33,34 
The thinning and infiltration of the fibrous cap is thought to prelude plaque rupture.23,35 
Following plaques rupture, the highly thrombogenic content of the plaque including tissue 
factor is exposed to the bloodstream, which can induce and sustain thrombus formation at the 
rupture site.36 
Another type of plaque surface degeneration is plaque erosion, which constitutes an additional 
risk factor for thrombus formation. Plaque erosions are characterized by absence of surface 
endothelium.37 Contrary to ruptured plaques, a prominent lipid core and interruption of the 
fibrous cap with exposure of the plaque interior to the lumen are absent. In addition, few 
macrophages and T-lymphocytes are typically present close to the lumen.23 It is unclear why 
some lesions rupture and others erode. 
Neo-angiogenesis within the lipid-rich necrotic core has been shown to be a source of 
intraplaque hemorrhage and is associated with plaque progression.38 The origin of intraplaque 
hemorrhage is uncertain. It has been postulated that these hemorrhages may be related to 
rupture of the fibrous cap.39,40 Another hypothesis of intraplaque hemorrhage development is 
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rupture of the vasa vasorum or of the immature newly formed vessels through 
neovascularization.41 By contributing to the deposition of free cholesterol, macrophage 
infiltration, and enlargement of the necrotic core, the accumulation of erythrocyte membranes 
within an atherosclerotic plaque as a result of intraplaque hemorrhage may represent a potent 
atherogenic stimulus increasing the risk of plaque destabilization.42  
Several imaging characteristics of atherosclerotic plaques in the carotid arteries have been 
associated with plaque vulnerability and subsequent the occurrence of clinical events. 
Examples of such imaging characteristics include degree of stenosis, plaque volume, plaque 
composition, plaque surface morphology, degree of inflammation, neovascularization, arterial 
stiffness, and shear stress.43-47 Ulceration of carotid plaques as seen on vessel imaging is 
related to the presence of plaque rupture on pathological examination, and is seen most often 
in the proximal (upstream) part where shear stress is highest.48 
 
Plaque healing 
After plaque rupture healing of the affected plaque may occur. A basis of a disrupted fibrous 
cap with an overlying repair reaction has been observed during pathological 
examination.49 Healed coronary plaques may reveal several alternating layers of necrotic core 
and fibrous tissue, with the older rupture sites located in the deeper layers and sequent lesion 
progression due to more recent superficial plaque ruptures.50 Whereas plaque rupture 
promotes thrombus formation with the risk of thromboembolic ischemic stroke, lesion 
progression due to repeated rupture healing increases plaque volume and luminal narrowing. 
Plaque ruptures do not always lead to ischemic events and are often asymptomatic.48  
 
Brain and vascular imaging in patients with TIA or stroke 
Patients with TIA and minor ischemic stroke are at high risk of early recurrent stroke. Urgent 
clinical diagnosis is therefore needed to determine the pathophysiology of TIA or minor stroke 
thereby modifying risk factors and accomplishing tailored therapy. The risk of a recurrent 
ischemic stroke is increased in patients with a clinically defined TIA along with a recent infarct 
on CT.51 Up to 20–50% of patients with a TIA based on clinical assessment may have acute 
ischemic lesions on diffusion weighted MRI, which is associated with an increased risk of 
stroke recurrence. 52-54 Nonetheless, at the time of writing of the studies in this thesis, it was 
not demonstrated yet that diffusion weighted MRI improves stroke recurrence risk prediction 
in addition to clinical risk scores.55  
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CT is the most widespread and cost-effective imaging modality used to assess patients with 
suspected stroke.56 The technique is widely available, fast, easy to use, and less expensive 
than MRI. Several brain pathologies may present with transient neurological symptoms which 
are hard to distinguish from a TIA or ischemic stroke based on clinical presentation alone. 
Some of these mimicking pathologies include intracerebral hemorrhage, subdural hematoma 
and tumors, which can often be reliably diagnosed with CT.56 In patients with moderate to 
severe stroke symptoms, ischemic changes are present on CT within the first few hours in up 
to two thirds of the patients.57-61 On the other hand, in minor ischemic stroke ischemic changes 
are hardly seen on CT compared to MRI, especially within the first few hours after onset of 
symptoms.57,61,62,64,65 In addition, several other conditions mimicking TIA or minor ischemic 
stroke such as multiple sclerosis, encephalitis, and hypoxic brain damage are better detected 
with MRI.57  
In order to resolve the underlying pathophysiology of the event, vascular imaging should be 
performed promptly alongside brain imaging to identify pathological lesions in the large 
extracranial and intracranial arteries. The main aim is to identify patients with a significant 
symptomatic carotid artery stenosis who could benefit from endarterectomy or angioplasty. 
Traditionally, digital subtraction angiography (DSA) was used for this purpose. However, intra-
arterial angiography has a 1–3% risk of causing a stroke in patients with symptomatic carotid 
lesions.66,67 In comparison, non-invasive imaging with duplex imaging, CT angiography (CTA), 
or contrast-enhanced MR angiography (MRA) are relatively risk-free. The latter techniques are 
therefore currently used to screen for carotid artery stenosis. Contrast enhanced MRA is the 
most sensitive and specific non-invasive imaging modality for assessment of carotid artery 
stenosis, however it is closely followed by Doppler ultrasound and CTA. Non-contrast MRA is 
less reliable.68,69 In addition, contrast enhanced MRA and CTA offer better non-invasive 
imaging of the intracranial vertebral and basilar arteries.70  
Simultaneous assessment of the severity of stenosis and plaque characteristics with non-
invasive imaging techniques may improve risk stratification for new and recurrent ischemic 
strokes. Ultimately, patients may benefit from tailored medical treatment reducing plaque 
vulnerability or from selective invasive revascularization therapy. 
 
Digital subtraction angiography 
This invasive imaging technique has been the gold standard technique for assessment of 
stenosis in large extracranial and intracranial arteries.24,71 With DSA the contours of the lumen 
of arteries is depicted when filled with radiopaque contrast. It does not depict the 
atherosclerotic plaque itself, hereby limiting assessment of plaque vulnerability. Nonetheless 
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a number of studies have assessed plaque surface characteristics by means of DSA. Plaque 
surface irregularity and ulceration were independently associated with ipsilateral ischemic 
stroke.72,73 DSA has a moderate sensitivity of 46-69% for the detection of ulcerations when 
compared to histology.73,74  
 
Magnetic resonance imaging 
Magnetic resonance imaging (MRI) has been shown to be capable of demonstrating several 
atherosclerotic plaque characteristics associated with plaque vulnerability. MRI allows the 
detection and quantification of the fibrous cap, lipid-rich necrotic core, and has a good 
sensitivity with a moderate-to-good specificity to detect and quantify intraplaque 
hemorrhage.75-80 The delineation of the lipid-rich necrotic core from surrounding fibrous tissue 
can be improved using gadolinium contrast enhanced images.81 Adventitial neovascularity can 
be visualize and quantified with dynamic contrast enhanced MRI which correlates with 
neovascularity and macrophages in histology specimens.82  
 
Multidetector computed tomography angiography  
MDCT has several advantages in comparison with conventional spiral CT. MDCT has a high 
acquisition speed. Importantly, MDCT acquires volume data instead of individual slice data 
with an increased coverage of the patient and a high spatial resolution. These characteristics 
combined with the capability to generate thin-slice acquisitions provide imaging voxels that are 
effectively isotropic (equal in size in all dimensions). Using these isotropic data, images can 
be reformatted and viewed in different planes without tradeoff in image integrity.  
Multidetector computed tomography angiography (MDCTA) provides rapid and reliable 
evaluation of atherosclerotic steno-occlusive disease in extracranial and intracranial arteries, 
and is available in most European hospitals. 83-85 The technique is effective in the detection of 
carotid plaque ulceration with a sensitivity and specificity of 94% and 99% respectively.86 
Furthermore, distinct plaque components as well as plaque volume can be quantified in good 
correlation with histology.87,88 Importantly, MDCTA has been demonstrated to be superior in 
the detection of intracranial as well as extracranial arterial stenosis. A sensitivity of 97% and a 
specificity of 99% have been reported.84 In addition, MDCTA allows differentiation between 
calcified and non-calcified atherosclerotic plaques.89  
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Objectives of this thesis 
This thesis aims to improve understanding of atherosclerotic carotid plaque ulcerations as a 
source of artery-to-artery thromboembolism in patients with TIA and ischemic stroke (Chapter 
2). Furthermore, the prevalence of intracranial arterial stenosis (IAS) in patients with TIA or 
ischemic stroke was determined and the risk of recurrent ischemic stroke was assessed in 
patients with both symptomatic and asymptomatic IAS (Chapter 3).  
 
Chapter 2 
Besides the severity of carotid artery stenosis, atherosclerotic plaque ulceration on intra-
arterial contrast angiography is a strong independent predictor of stroke.73,90 Microscopic 
evaluation of atherosclerotic plaques has shown that ulceration and irregularities detected by 
angiography are strongly associated with the presence of plaque rupture, plaque hemorrhage, 
a large lipid core size and less fibrous tissue.39 Plaque ulceration has been more frequently 
observed proximal to the point of maximum luminal stenosis, which is exposed to higher wall 
shear stress.41,48 In Chapter 2.1 we assess the associations between carotid artery 
atherosclerotic plaques surface morphology and severity of stenosis, cardiovascular risk 
factors, and type of ischemic cerebrovascular symptoms. 
Whereas lacunar strokes are associated with local occlusive disease of the deep perforating 
arteries at the base of the brain, large deep and cortical ischemic strokes are frequently caused 
by thromboembolism from extracranial arteries or the heart.91,92 However, no striking 
differences have been reported in cardiovascular risk profiles of these two stroke subtypes. 
Nonetheless, atrial fibrillation and carotid stenosis are both more common in non-lacunar 
stroke.93 Plaque rupture with subsequent thrombus formation and embolization of plaque 
material or thrombus into the intracranial circulation may cause non-lacunar stroke. In Chapter 
2.2 we test this hypothesis by evaluating whether carotid plaque ulceration is more associated 
with non-lacunar stroke than with lacunar stroke.  
Histological and non-invasive imaging studies assessing the relation of carotid plaque 
characteristics with plaque surface disruption has been limited to patients with a ≥50% carotid 
stenosis.39,94 In patients with severe symptomatic stenosis, carotid plaque ulceration has been 
associated with the presence of fibrous cap rupture and distinct plaque components such as 
intraplaque hemorrhage, large lipid core, and less fibrous tissue.39 However, a ≥50% carotid 
stenosis is present in only approximately 10% of patients with amaurosis fugax, TIA or minor 
ischemic stroke.95 Whereas two-third of carotid plaque ulcerations is observed in carotid 
arteries with a low degree stenosis (0-49%),96 little is known about the relation between carotid 
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plaque characteristics and plaque ulceration in these patients. Also, limited data are available 
on the association between plaque volume and carotid plaque surface disruption.94 In Chapter 
2.3 we analyze the relation between atherosclerotic carotid plaques ulceration and plaque 
volume, degree of stenosis, and plaque components as assessed with MDCTA in both patients 
with ≥50% stenosis as well as in those with a low degree stenosis (0-49%).  
While there is evidence of a healing process of ruptured atherosclerotic plaques in the coronary 
arteries which contributes to an increase in the degree of luminal narrowing, little is known 
about the healing process of plaque ruptures in carotid arteries.49,50 Current knowledge about 
the evolution of atherosclerotic plaque rupture is mainly based on histological analysis of 
coronary arteries in autopsy studies or carotid plaque specimens obtained from carotid 
endarterectomy.97-101 However, for extensive investigation of the temporal changes of plaque 
surface characteristics and their relation with recurrent thrombo-embolic events, longitudinal 
non-invasive serial imaging studies are required. To explore the natural history of ulcerated 
plaques and to assess whether plaque ulcerations heal, we study the temporal changes in 




Intracranial arterial stenosis (IAS) in patients with TIA or ischemic stroke is associated with a 
high risk of recurrent stroke.102 The prevalence of IAS seems to vary among ethnic groups.103 
Nevertheless, only limited studies have assessed the prevalence and associated risk factors 
for IAS in European stroke patients.104-106 Moreover, the comparative value of studies available 
in European patients is limited by the use of multiple imaging modalities. Also, little is known 
about the composition of IAS lesions, which may point to a specific pathophysiological 
process.107 The pathophysiology of intracranial atherosclerosis is suggested to differ from that 
of the extracranial arteries.108 A prominent role for inflammatory factors is indicated in the 
atherosclerosis of the intracranial arteries.109 Consequently, the pro-atherogenic influence of 
inflammatory reactions could be demonstrated by an association between the erythrocyte 
sedimentation rate (ESR) and IAS, as previously observed in a single study.110 In addition, an 
accelerated intracranial atherogenesis could be reflected in differences in plaque calcification. 
In Chapter 3.1 we evaluate a large cohort of patients with TIA or ischemic stroke for the 
prevalence, distribution and the calcification of IAS lesions using MDCTA. Furthermore, the 
association of IAS with the traditional risk factors for cerebrovascular disease as well as with 
ESR was investigated.  
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IAS accounts for around 8–10% of all ischemic strokes.14,111 Recurrence rates of 10% to 14% 
per year have been reported in patients with previously symptomatic IAS.102,104,112,113 A few 
studies have been published on the stroke recurrence risk in patients with asymptomatic IAS. 
However, these studies were limited to IAS in middle cerebral arteries alone or to coexisting 
asymptomatic IAS in patients with symptomatic IAS.114-116 Thus far, the ischemic stroke 
recurrence risk for both symptomatic and asymptomatic IAS has not been compared in a 
consecutive of cohort transient ischemic attack (TIA) and ischemic stroke patients. In Chapter 
3.2, we evaluate the occurrence of new ischemic strokes in patients with symptomatic and 
asymptomatic IAS as well as patients without IAS during long term follow-up.  
Finally, in Chapter 4, we put our main findings in the context of current knowledge on 
extracranial and intracranial atherosclerotic disease. 
  
- 20 - 
 
References  
1.  Young J, Forster A. Review of stroke rehabilitation. BMJ. 2007 Jan 13;334:86-90. 
2.  Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 
2005;4:752-759. 
3.  Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from 
the american heart association. Circulation. 2011;123:e18–e209. 
4. European Registers of Stroke (EROS) Investigators, Heuschmann PU, Di Carlo A, Bejot Y, Rastenyte D, 
Ryglewicz D, Sarti C, Torrent M, Wolfe CD. Incidence of stroke in Europe at the beginning of the 21st 
century. Stroke. 2009;40:1557-1563. 
5. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 
age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 
2012; 380:2095-2128.  
6. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific 
statement for healthcare professionals from the American Heart Association/American Stroke Association 
Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology 
and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral 
Vascular Disease. The American Academy of Neurology affirms the value of this statement as an 
educational tool for neurologists. Stroke. 2009;40:2276-2293. 
7. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement 
for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 
2013;44:2064-2089. 
8. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 
2007;6:182-187. 
9. Warlow C, et al. Stroke. Lancet. 2003;362:121 1-24. 
10.  https://www.hartstichting.nl/getmedia/41cf66bf-2107-44d6-b2c3-739fc465ec73/cijferboek-hartstichting-
hart-vaatziekten-nederland-2019-rp92.pdf. 
11. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-
2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383:245. 
12. Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA. International comparison 
of stroke cost studies. Stroke. 2004;35:1209-1215. 
13. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke 
Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American 
Heart Association. Circulation. 2012;125:e2-e220. 
14. European Heart Network, Brussels. European cardiovascular disease statistics 2008. 
15. Schreiber S, Serdaroglu M, Schreiber F, Skalej M, Heinze HJ, Goertler M. Simultaneous occurrence and 
interaction of hypoperfusion and embolism in a patient with severe middle cerebral artery stenosis. Stroke. 
2009;40:e478-80.  
- 21 - 
 
16. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol. 1968;12:1–15. 
17. Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. 
Neurology 1989;39:1246. 
18. Caplan LR, Manning W (Eds). Brain embolism. Informa Healthcare, New York 2006.  
19. Amarenco P, Duyckaerts C, Tzourio C, et al. The prevalence of ulcerated plaques in the aortic arch in 
patients with stroke. N Engl J Med 1992;326:221-225. 
20. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic 
stroke. N Engl J Med 1994;331:1474-1479. 
21. Cohen A, Tzourio C, Bertrand B, et al. Aortic plaque morphology and vascular events: a follow-up study in 
patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 
1997;96:3838-3841. 
22. Di Tullio MR, Russo C, Jin Z, et al. Aortic arch plaques and risk of recurrent stroke and death. Circulation 
2009;119:2376–2382. 
23. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive 
morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 
2000;20:1262–1275. 
24. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid 
endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:445–453. 
25. Kistler JP, Buonanno FS, Gress DR. Carotid endarterectomy--specific therapy based on pathophysiology. 
N Engl J Med 1991;325:505-507. 
26. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or 
with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 
1991;337:1235–1243. 
27. Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in 
symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 
1991;266:3289–3294. 
28. Suwanwela N, Can U, Furie KL, et al. Carotid Doppler ultrasound criteria for internal carotid artery stenosis 
based on residual lumen diameter calculated from en bloc carotid endarterectomy specimens. Stroke 
1996;27:1965–1969. 
29. Can U, Furie KL, Suwanwela N, et al. Transcranial Doppler ultrasound criteria for hemodynamically 
significant internal carotid artery stenosis based on residual lumen diameter calculated from en bloc 
endarterectomy specimens. Stroke 1997;28:1966–1971. 
30. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of 
atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, 
American Heart Association. Circulation 1994;89:2462–2478. 
- 22 - 
 
31. Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding 
early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol 2007;27:986-
989. 
32. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and 
a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the 
Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374. 
33. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary 
disease who died suddenly. N Engl J Med 1997; 336:1276-1282. 
34. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to 
vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 
2003;108:1772-1778.  
35. Davies MJ, Thomas AC. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic 
death, and crescendo angina. Br Heart J 1985;53:363-373. 
36. Nemerson Y. A simple experiment and a weakening paradigm: the contribution of blood to propensity for 
thrombus formation. Arterioscler Thromb Vasc Biol 2002;22:1369. 
37. Kolodgie FD, Burke AP, Farb A, et al. Differential accumulation of proteoglycans and hyaluronan in culprit 
lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 2002;22:1642-1648. 
38. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque 
progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler 
Thromb Vasc Biol. 2005;25:2054-2061.  
39. Davies MJ, Thomas AC: Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic 
death, and crescendo angina. Br Heart J 1985;53:363-373. 
40. Kampschulte A, Ferguson MS, Kerwin WS, Polissar NL, Chu B, Saam T, et al. Differentiation of intraplaque 
versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo 
magnetic resonance imaging. Circulation 2004;110:3239-3244. 
41. Saam T, Hatsukami TS, Takaya N, Chu B, Underhill H, Kerwin WS, et al. The vulnerable, or high-risk, 
atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 
2007;244:64-77. 
42. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and 
progression of coronary atheroma. N Engl J Med 2003;349:2316-2325.  
43. Naghavi M, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk 
assessment strategies: Part I. Circulation. 2003;108:1664-1672.  
44. Lovett JK, et al. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. 
Circulation. 2004;1 10:2190-2197. 
45. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol. 2003;41:155-225.  
- 23 - 
 
46. Slager CJ, Wentzel JJ, Gijsen FJ, Thury A, van der Wal AC, Schaar JA, Serruys PW. The role of shear 
stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract 
Cardiovasc Med. 2005;2:456-464.  
47. Oliver JJ, et al. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. 
ArteriosclerThromb Vasc Biol. 2003;23:554-566. 
48. Lovett JK, Rothwell PM. Site of Carotid Plaque Ulceration in Relation to Direction of Blood Flow: An 
Angiographic and Pathological Study. Cerebrovasc Dis 2003;16:369-375. 
49. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque 
disruption. Heart 1999;82:265-268. 
50. Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that 
subclinical rupture has a role in plaque progression. Circulation 2001;103:934-940. 
51. Douglas V, Johnston C, Elkins J, Sidney S, Gress D, Johnston GS: Head computed tomography findings 
predict short-term stroke risk after transient ischemic attack. Stroke 2003;34:2894-2898. 
52. Gonzalez R, Koroshetz W: ‘Footprints’ of transient ischemic attacks: a diffusion-weighted MRI study. 
Cerebrovasc Dis 2002;14:177-186. 
53. Crisostomo R, Garcia M, Tong D. Detection of diffusion-weighted MRI abnormalities in patients with 
transient ischemic attack: correlation with clinical characteristics. Stroke 2003;34:932-937. 
54. Coutts S, Simon J, Eliasziw M, Sohn C, Hill M, Barber P, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott 
J, Buchan A, Demchuk A. Triaging transient ischemic attack and minor stroke patients using acute 
magnetic resonance imaging. Ann Neurol 2005;57:848-854. 
55. Redgrave J, Coutts S, Schulz U, Briley D, Rothwell P. Systematic review of associations between the 
presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke 
risk after transient ischemic attack. Stroke 2007;38:1482-1488. 
56. Wardlaw JM, Keir SL, Seymour J, Lewis S, Sandercock PA, Dennis MS, Cairns J: What is the best imaging 
strategy for acute stroke? Health Technol Assess 2004;8:1-180. 
57. Chalela J, Kidwell C, Nentwich L, Luby M, Butmann J, Demchuk A, Hill M, Patronas N, Latour L, Warach 
S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with 
suspected acute stroke: a prospective comparison. Lancet 2007;369:293-298. 
58. Von Kummer R, Bourquain H, Bastianello S, Bozzao L, Manelfe C, Meier D, Hacke W. Early prediction of 
irreversible brain damage after ischemic stroke by computed tomography. Radiology 2001;219:95-100. 
59. Von Kummer R, Allen K, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier D, 
Hacke W: Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 
1997;205:327-333. 
60. Barber P, Demchuk A, Zhang J, Buchan A. Validity and reliability of a quantitative computed tomography 
score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670-
1674. 
- 24 - 
 
61. Wardlaw J, Mielke O. Early signs of brain infarction at CT: Observer reliability and outcome after 
thrombolytic treatment – systematic review. Radiology 2005;235:444-453. 
62. Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute 
intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35:502-506.  
63. Grotta JC, Chiu D, Lu M, et al. Agreement and variability in the interpretation of early CT changes in stroke 
patients qualifying for intravenous rtPA therapy. Stroke. 1999;30:1528-1533.  
64. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral 
hemorrhage. JAMA. 2004;292:1823-1830.  
65. Wardlaw J, West T, Sandercock P, Lewis S, Mielke O. The International Stroke Trials Collaborative Group: 
Visible infarction on computed tomography is an independent predictor of poor functional outcome after 
stroke, and not of haemorrhagic transformation. JNNP 2003;74:452-458. 
66. Forsting M, Wanke I. Funeral for a friend. Stroke 2003;34:1324-1332. 
67. Willinsky R, Taylor S, TerBrugge K, Farb R, Tomlinson G, Montanera W. Neurologic complications of 
cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 
2003;227:522-528. 
68. Wardlaw J, Chappell F, Best J, Wartolowska K, Berry E. On behalf of the NHS R&D Health Technology 
Assessment Carotid Stenosis Imaging Group: Non-invasive imaging compared with intra-arterial 
angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 2006;367:1503-
1512. 
69. Wardlaw JM, Chappell FM, Stevenson M, et al. Accurate, practical and cost-effective assessment of 
carotid stenosis in the UK. Health Technol Assess 2006;10:1-182. 
70. Khan S, Cloud G, Kerry S, Markus H. Imaging of vertebral artery stenosis: a systematic review. J Neurol 
Neurosurg Psychiatry 2007;78:1218-1225. 
71. European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently 
symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 
1998;351:1379-1387. 
72. Eliasziw M, et al. Significance of plaque ulceration in symptomatic patients with high- grade carotid 
stenosis. North American Symptomatic Carotid Endarterectomy Trial. Stroke. 1994;253:304-308. 
73. Rothwell PM, et al. Interrelation between plaque surface morphology and degree of stenosis on carotid 
angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the 
European Carotid Surgery Trialists’ Collaborative Group. Stroke. 2000;31:615-621.  
74. Streifler JY, et al. Angiographic detection of carotid plaque ulceration. Comparison with surgical 
observations in a multicenter study. North American Symptomatic Carotid Endarterectomy Trial. Stroke. 
1994;25:1130-1132.  
75. Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B, et al. In vivo quantitative measurement 
of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-
resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112:3437-
3444.  
- 25 - 
 
76. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, et al. Quantitative evaluation of carotid 
plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005;25:234-239.  
77. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human 
atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 
2000;102:959-964.  
78. Ota H, Yarnykh VL, Ferguson MS, Underhill HR, Demarco JK, Zhu DC, et al. Carotid intraplaque 
hemorrhage imaging at 3.0-T MR imaging: comparison of the diagnostic performance of three T1-weighted 
sequences. Radiology 2010;254:551-563.  
79. Ota H, Yu W, Underhill HR, Oikawa M, Dong L, Zhao X, et al. Hemorrhage and large lipid-rich necrotic 
cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler 
Thromb Vasc Biol 2009;29:1696-1701.  
80. Saam T, Hetterich H, Hoffmann V, Yuan C, Dichgans M, Poppert H, et al. Meta-analysis and systematic 
review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic 
resonance imaging. J Am Coll Cardiol 2013;62:1081-1091.  
81. Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, et al. Contrast-enhanced high resolution 
MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62-67.  
82. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS: MR imaging of adventitial vasa vasorum in 
carotid atherosclerosis. Magn Reson Med 2008;59:507-514.  
83. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB. Systematic review of computed tomographic 
angiography for assessment of carotid artery disease. Stroke. 2004; 35:2306-2312. 
84. Nguyen-Huynh MN, Wintermark M, English J, Lam J, Vittinghoff E, Smith WS, Johnston SC. How accurate 
is CT angiography in evaluating intracranial atherosclerotic disease? Stroke. 2008;39:1184-1188. 
85. Balucani C, Leys D, Ringelstein EB, Kaste M, Hacke W. Executive Committee of the European Stroke 
Initiative. Detection of intracranial atherosclerosis: which imaging techniques are available in European 
hospitals? Stroke. 2009;40:726-729. 
86. Saba L, Caddeo G, Sanfilippo R, Montisci R, Mallarini G. Efficacy and sensitivity of axial scans and different 
reconstruction methods in the study of the ulcerated carotid plaque using multidetector-row CT 
angiography: comparison with surgical results. AJNR Am J Neuroradiol. 2007;28:716-723. 
87. de Weert TT, Ouhlous M, Meijering E, Zondervan PE, Hendriks JM, van Sambeek MR, Dippel DW, van 
der Lugt A. In vivo characterization and quantification of atherosclerotic carotid plaque components with 
multidetector computed tomography and histopathological correlation. Arterioscler Thromb Vasc Biol. 
2006;26:2366-2372.  
88. Wintermark M, Jawadi SS, Rapp JH, Tihan T, Tong E, Glidden DV, Abedin S, Schaeffer S, Acevedo-Bolton 
G, Boudignon B, Orwoll B, Pan X, Saloner D. High-resolution CT imaging of carotid artery atherosclerotic 
plaques. AJNR Am J Neuroradiol. 2008;29:875-882. 
89. Cordeiro MA, Lima JA. Atherosclerotic plaque characterization by multidetector row computed tomography 
angiography. J Am Coll Cardiol. 2006;47;40-47. 
- 26 - 
 
90. Eliasziw M, Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJ. Significance of plaque ulceration 
in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid 
Endarterectomy Trial. Stroke. 1994;25:304-308  
91. Fisher CM. Lacunar strokes and infarcts: A review. Neurology. 1982;32:871-876.  
92. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet. 2003;362:1211–1224. 
93. Jackson C, Sudlow C. Are Lacunar Strokes Really Different? A Systematic Review of Differences in Risk 
Factor Profiles Between Lacunar and Nonlacunar Infarct. Stroke. 2005;36:891-904.  
94. Underhill HR, Yuan C, Yarnykh VL, Chu B, Oikawa M, Dong L, Polissar NL, Garden GA, Cramer SC, 
Hatsukami TS. Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. 
AJNR Am J Neuroradiol. 2010;31:487-493. 
95. Tholen AT, de Monyé C, Genders TS, Buskens E, Dippel DW, van der Lugt A, Hunink MG. Suspected 
carotid artery stenosis: cost-effectiveness of CT angiography in work-up of patients with recent TIA or 
minor ischemic stroke. Radiology. 2010;256:585-597. 
96. de Weert TT, Cretier S, Groen HC, Homburg P, Cakir H, Wentzel JJ, Dippel DW, van der Lugt A. 
Atherosclerotic plaque surface morphology in the carotid bifurcation assessed with multidetector computed 
tomography angiography. Stroke. 2009;40:1334-1340. 
97. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R: Concept of vulnerable/unstable plaque. Arterioscler 
Thromb Vasc Biol;30:1282-1292. 
98. Kolodgie FD, Virmani R, Burke AP, Farb A, Weber DK, Kutys R, Finn AV, Gold HK: Pathologic assessment 
of the vulnerable human coronary plaque. Heart 2004;90:1385-1391. 
99. Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, Pasterkamp G: Carotid atherosclerotic 
plaques stabilize after stroke: Insights into the natural process of atherosclerotic plaque stabilization. 
Arterioscler Thromb Vasc Biol 2009;29:128-133. 
100. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM: Histological assessment of 526 symptomatic carotid 
plaques in relation to the nature and timing of ischemic symptoms: The Oxford Plaque Study. Circulation 
2006;113:2320-2328. 
101. Virmani R, Finn AV, Kolodgie FD: Carotid plaque stabilization and progression after stroke or TIA. 
Arterioscler Thromb Vasc Biol 2009;29:3-6. 
102. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, 
Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ. Predictors of ischemic stroke in the 
territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563. 
103. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial 
atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26:14-20. 
104. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F. Prospective study of 
symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66:1187-1191. 
- 27 - 
 
105. Arenillas JF, Molina CA, Chacón P, Rovira A, Montaner J, Coscojuela P, Sánchez E, Quintana M, Alvarez-
Sabín J. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. 
Neurology. 2004;63:27-32. 
106. Weimar C, Goertler M, Harms L, Diener HC. Distribution and outcome of symptomatic stenoses and 
occlusions in patients with acute cerebral ischemia. Arch Neurol. 2006;63:1287-1291. 
107. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide 
burden but a relatively neglected frontier. Stroke. 2008;39:2396-2399. 
108. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento MR, Crimi G, Abete P, Palinski W, 
Condorelli M, Napoli C. Age-related effects on atherogenesis and scavenger enzymes of intracranial and 
extracranial arteries in men without classic risk factors for atherosclerosis. Stroke. 2001;32:2472-2478. 
109. Arenillas JF, Alvarez-Sabín J, Molina CA, Chacón P, Montaner J, Rovira A, Ibarra B, Quintana M. C-
reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients 
with intracranial large-artery occlusive disease. Stroke. 2003;34:2463-2468. 
110. De Silva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC. South Asian patients with ischemic 
stroke: intracranial large arteries are the predominant site of disease. Stroke. 2007;38:2592-2594. 
111. Wityk R, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral 
atherosclerosis. Stroke. 1996;27:1974-1980. 
112. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, et al. The Warfarin-Aspirin 
Symptomatic Intracranial Disease study. Neurology. 1995;45:1488-1493. 
113. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive 
medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003. 
114. Kern R, Steinke W, Daffertshofer M, Prager R, Hennerici M. Stroke recurrences in patients with 
symptomatic vs asymptomatic middle cerebral artery disease. Neurology. 2005;65:859–864.  
115. Kremer C, Schaettin T, Georgiadis D, Baumgartner RW. Prognosis of asymptomatic stenosis of the middle 
cerebral artery. J Neurol Neurosurg Psychiatry. 2004;75:1300-1303. 
116. Nahab F, Cotsonis G, Lynn M, Feldmann E, Chaturvedi S, Hemphill JC, et al; WASID Study Group. 
Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke. 2008;39:1039-1041.
  
- 28 - 
 
  
- 29 - 
 
 
Chapter 2  
 
Carotid artery plaque ulceration  
- 30 - 
 
  
- 31 - 
 
Chapter 2.1  
 
Atherosclerotic plaque surface morphology in 
the carotid bifurcation assessed with 
multidetector computed tomography 
angiography 
 
T.T. de Weert, S. Cretier, H.C. Groen, P.J. Homburg, H. Cakir, J.J Wentzel, D.W.J. Dippel, A. 
van der Lugt  
 
Stroke. 2009;40:1334-1340. doi: 10.1161/STROKEAHA.108.538439 
  




Background and Purpose: Complicated (irregular or ulcerated) carotid plaques have proven 
to be independent predictors of stroke. We analyzed the frequency and location of plaque 
irregularities in a large cohort of patients with ischemic cerebrovascular disease and the 
relation with severity of stenosis, cardiovascular risk factors, and symptomatology. 
Methods: Multidetector CT angiography images from 406 patients were evaluated. Plaque 
surface morphology was classified as smooth, irregular, or ulcerated. The location of the 
ulceration was defined as proximal or distal to the point of maximum stenosis. 
Results: Atherosclerotic plaques with an open lumen were present in 448 carotid arteries; 
these plaques were classified as: smooth, 276 (62%); irregular, 99 (22%); and ulcerated, 73 
(16%). Sixty-two (69%) of the ulcerations were located proximal to the point of maximum 
luminal stenosis. Complicated plaques were significantly (P<0.001) more common in carotid 
arteries with stenosis >30% than in those with stenosis <30%. There is an association between 
complicated plaques and hypercholesterolemia (OR, 3.0) and a trend toward an association 
with smoking (OR, 1.9). Complicated plaques are more often present in the symptomatic 
carotid artery than in the contralateral asymptomatic carotid artery; however, this is fully 
attributed to a significantly higher degree of stenosis in the symptomatic arteries. 
Conclusions: Multidetector CT angiography allows the classification of atherosclerotic carotid 
plaque surface. Complicated plaques are frequent in atherosclerotic carotid disease, especially 
with higher stenosis degree. Ulcerations are mostly located in the proximal part of the 
atherosclerotic plaque. Hypercholesterolemia and smoking are related with the presence of 
complicated plaques. 
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Introduction 
Cerebral infarction is one of the most important causes of death and the greatest cause of 
disability in the Western world. Approximately 20% to 30% of the infarcts can be related to 
carotid artery stenosis.1,2 The severity of stenosis is an important predictor of (recurrent) 
ischemic cerebrovascular events and is used in therapeutic decision-making; patients with 
symptomatic or asymptomatic carotid stenosis above a certain degree are considered 
candidates for carotid intervention such as carotid endarterectomy or stent placement. 
Besides the severity of stenosis, plaque ulceration on intra-arterial contrast angiography is a 
strong independent predictor of stroke.3,4 It is current opinion that atherosclerotic plaque 
rupture plays an important role in acute events, like transient ischemic accidents (TIAs) and 
stroke.5 Rupture-prone plaques have specific morphological features; the most frequently seen 
vulnerable plaque type has a large lipid-rich core with a thin fibrous cap and has proved to be 
an independent predictor of ischemic cerebrovascular events.5-7 With microscopic evaluation 
of the plaque, it became clear that angiographic ulceration and irregularities were strongly 
associated with the presence of plaque rupture, plaque hemorrhage, a large lipid core size, 
and less fibrous tissue. These features are all closely related with the concept of a vulnerable 
plaque.8 Plaque ulceration has been more frequently observed proximal to the point of 
maximum luminal stenosis, which is exposed to higher wall shear stress.9,10 
The accuracy of digital subtraction angiography (DSA) in the detection of ulceration, with 
surgical observations as reference, has been reported to be low (sensitivity 46% and specificity 
74%).11 The first reports on the accuracy of CT angiography (CTA) compared with DSA in the 
assessment of plaque ulcers were disappointing, but this might be explained by the rather thick 
slice thickness used with single-section CT.12 A later report demonstrated that CTA was 
superior to DSA in the detection of plaque irregularities and ulcerations.13 Walker and 
colleagues evaluated 165 CTA studies, compared them with endarterectomy specimens, and 
reported a sensitivity of 60% and a specificity of 74%.14 A recent multidetector CTA (MDCTA) 
study reported an even higher sensitivity and specificity for the detection of ulcerations (94% 
and 99%, respectively).15 
The purpose of this study was to assess atherosclerotic plaque surface morphology in the 
carotid arteries with MDCTA in a large consecutive cohort of patients with ischemic 
cerebrovascular disease. Plaque surface morphology was related to severity of stenosis, 
cardiovascular risk factors, and type of ischemic cerebrovascular symptoms. 
  
- 34 - 
 
Materials and Methods 
 
Study Population 
Consecutive patients (n=406) with ischemic cerebrovascular disease, including amaurosis 
fugax or focal cerebral ischemia (TIA and minor ischemic stroke), were prospectively studied. 
Patients were enrolled from the neurology department’s specialized TIA/stroke outpatient clinic 
or neurology ward. Patients underwent neurological examination on admission. Medical history 
was recorded from all patients. All patients underwent multidetector CT of the brain and 
MDCTA of the carotid arteries. In all patients, MDCTA has been performed as part of a 
research protocol that was approved by the Institutional Review Board and all patients had 
given written informed consent. The inclusion period ranged from November 2002 to January 
2005. 
Scanning and Image Reconstruction 
Scanning was performed on a 16-slice multidetector CT scanner (Sensation 16; Siemens, 
Erlangen, Germany) with a standardized optimized contrast-enhanced protocol (120 kVp, 180 
mAs, collimation 16×0.75 mm, pitch 1).16,17 The MDCTA scan range reached from the 
ascending aorta to the intracranial circulation (2 cm above the sella turcica). All patients 
received 80 mL contrast material (320 mg/mL iodixanol, Visipaque; Amersham Health, Little 
Chalfont, UK) followed by 40 mL saline bolus chaser, both with an injection rate of 4 mL/s. 
Synchronization between the passage of contrast material and data acquisition was achieved 
by real-time bolus tracking at the level of the ascending aorta. The trigger threshold was set at 
an increase in attenuation of 75 Hounsfield units above baseline attenuation (approximately 
150 Hounsfield units in absolute Hounsfield units value). 
Image reconstructions were made with field of view 100 mm, matrix size 512×512 (real in-
plane resolution 0.6×0.6 mm), slice thickness 1.0 mm, increment 0.6 mm, and with an 
intermediate reconstruction algorithm.18 
Analysis of the Atherosclerotic Plaque 
The MDCTA images were sent to a standalone workstation (Leonardo-Siemens Medical 
Solutions, Forchheim, Germany) with dedicated 3-dimensional analysis software. On the 
workstation, both carotid bifurcations were evaluated with multiplanar reformatting software. 
With this software, oblique planes can be adjusted to evaluate the carotid bifurcation in multiple 
reformations in the short axis and long axes with respect to the carotid artery. 
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First, the presence of an atherosclerotic plaque was evaluated. The criterion used for the 
presence of an atherosclerotic lesion was the presence of a calcification and/or thickening of 
the vessel wall. If a plaque was visible, the surface of the plaque was evaluated and classified 
as ulcerated, irregular, or smooth (Figures 1 and 2). Plaques were classified as ulcerated if 
extension of contrast material was present beyond the vascular lumen into the surrounding 
plaque. Ulcerated plaques were categorized according to the shape of the ulcer as Type 1 to 
4 (Figure 2) as previously described by Lovett et al.8 Type 1 is an ulcer that points out 
perpendicular to the lumen; Type 2 has a narrow neck and points out proximally and distally; 
Type 3 has an ulcer neck proximally and points out distally, and Type 4 has an ulcer neck 
distally and points out proximally. The location of the ulcer was defined as proximal or distal to 
the point of maximum luminal stenosis. Plaques were classified as irregular if pre- or 
poststenotic dilatation was present and/or if the plaque surface morphology showed 
irregularities without any sign of ulceration. If the plaque was not ulcerated or irregular, it was 
classified as smooth. To calculate interobserver reproducibility, a second observer reassessed 
100 consecutive MDCTA scans.  
 
 
Figure 1. Multiplanar reformat images (1 mm thick). A, smooth atherosclerotic carotid plaque 
surface. B–C, irregular plaque surface. 
 
- 36 - 
 
 
Figure 2. Multiplanar reformat images (1 mm thick) with (A) Type 1, (B) Type 2, (C) Type 3, 
and (D) Type 4 atherosclerotic carotid plaque ulceration. 
 
Severity of Stenosis 
The severity of stenosis on CTA was measured according to the North American Symptomatic 
Carotid Endarterectomy Trial (NASCET) criteria.19 Oblique multiplanar reformatting images, 
parallel to the central lumen line, were used for measurements. The severity of stenosis was 
defined as the remaining lumen at the site of stenosis as percentage of the normal lumen distal 
to the stenosis and categorized into 0% to 29%, 30% to 49%, 50% to 69%, 70% to 99%, and 
100%. 
Cardiovascular Risk Factors 
Clinical measures and information on risk factors and medication were obtained at admission 
to the hospital. Subjects were categorized as current, past, and never smokers. Hypertension 
was defined as systolic blood pressure over 140 mm Hg and/or diastolic blood pressure over 
90 mm Hg during 2 episodes of at least 15 minutes of continuous noninvasive blood pressure 
measurement or treatment with antihypertensive medication. Blood pressure-lowering drugs 
comprised angiotensin-converting enzyme inhibitors, calcium antagonists, β-blockers, and 
diuretics. 
Hypercholesterolemia was defined as fasting cholesterol >5.0 mmol/L or on treatment with 
cholesterol-lowering drugs. Diabetes was defined as fasting serum glucose levels >7.9 
mmol/L, nonfasting serum glucose levels >11.0 mmol/L, or use of antidiabetic medication. 
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Information on previous cardiovascular disease (myocardial infarction, atrial fibrillation, angina 
pectoris, chronic heart failure, coronary artery bypass grafting) and previous ischemic 
cerebrovascular disease (TIA or ischemic stroke other than the event for which the patient was 
currently evaluated) was collected. 
Symptoms 
Amaurosis fugax was defined as a sudden, focal neurological deficit that was presumed to be 
of vascular origin and confined to the eye. TIA was defined as a sudden, focal neurological 
deficit that was presumed to be of vascular origin and was confined to an area of the brain 
perfused by a specific artery and that lasted <24 hours. In addition, no relevant infarct (one 
that explains the deficit) should be seen on the CT scan. An ischemic stroke was defined as a 
sudden focal neurological deficit that lasted >24 hours or which was accompanied by a relevant 
infarct on the CT scan. 
Statistics 
Data are presented as mean±SD. Analysis was performed for complicated (irregular or 
ulcerated) plaques. Reliability of assessment of plaque surface morphology was measured 
using the kappa statistics. Differences between categorical data and continuous data were 
analyzed with a χ2 test and a Mann-Whitney test or Student t test, respectively. In exploratory 
analysis, we evaluated the association between the presence of complicated plaque and 
possible determinants: severity of stenosis and cardiovascular risk factors (smoking, 
hypertension, hypercholesterolemia, diabetes, previous cardiovascular disease, previous 
ischemic cerebrovascular disease). All determinants were included in a multiple logistic 
regression model to assess their association with complicated plaque independently from other 
determinants. No stepwise procedures were used. The associations were expressed as ORs 
with 95% CIs, which implies we used P<0.05 as the value for statistical significance. The same 
analysis was repeated for ulcerated plaques only. Finally, in the patients with symptoms in the 
territory of the carotid arteries, the association between the presence of complicated plaque 
and symptomatic side was evaluated with a logistic regression model after adjustment for 
severity of stenosis. All calculations were made with SPSS 14.0 for Windows. 
 
Results 
The MDCTA images and medical histories of 406 patients were evaluated. Two patients were 
excluded because of poor image quality due to dental artifacts. General patient characteristics 
are shown in Table 1. With respect to age, the symptomatic artery, and ischemic 
cerebrovascular disease, there were no significant differences between men and women. 
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However, men were more frequently smokers and had more frequently experienced previous 
cardiac disease, whereas women had more frequently hypercholesterolemia. 
 










Age (mean  SD; years) 62 ± 14 62 ± 13 62 ± 14 0.57 
Symptomatic artery 
 Carotid 350 (87%) 212 (88%) 138 (85%) 
0.48 
 Vertebrobasilar 54 (13%) 30 (12%) 24 (15%) 
Cerebrovascular symptoms 
 
Amaurosis fugax 83 (21%) 50 (21%) 33 (20%) 0.94 
Transient ischemic attack 122 (30%) 72 (30%) 50 (31%) 0.81 
 Minor stroke 199 (49%) 120 (50%) 79 (49%) 0.87 
Risk factors 
 
Smoking 195 (48%) 136 (56%) 59 (36%) <0.01 
Hypertension 288 (71%) 177 (73%) 111 (69%) 0.31 
Diabetes 61 (15%) 38 (16%) 23 (14%) 0.68 
Hypercholesterolemia 317 (78%) 177 (73%) 140 (86%) <0.01 
Previous cardiac disease 107 (26%) 73 (30%) 34 (21%) 0.04 
Previous cerebrovascular 
disease 
105 (26%) 70 (29%) 35 (21%) 0.10 
Data are number (percentage), or mean±SD.  
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In 142 patients (35%), both carotid arteries were free of atherosclerosis; in 68 patients (17%), 
presence of atherosclerosis was determined in one of the carotid arteries; in 190 patients 
(47%), both carotid arteries showed atherosclerosis and in 21 patients, at least one of the 
carotid arteries was occluded. Overall, from the 808 studied arteries, 337 (42%) were normal 
without atherosclerotic plaque, 448 (55%) were diseased, and 23 (3%) were occluded. 
 
Table 2. Plaque surface morphology characteristics of 448 atherosclerotic carotid arteries with 
number, type (Type 1-4) and location of plaque ulceration.  
Carotid arteries with atherosclerosis  
 Smooth surface 276 (62%) 
 Irregular surface 99 (22%) 
 Ulcerated surface 73 (16%) 
  Number of ulcerations per carotid artery 
 1 61 (84%) 
 2 8 (11%) 
 3 3 (4%) 
 4 1 (1%) 
  Type of ulceration 
 1 43 (48%) 
 2 12 (13%) 
 3 24 (27%) 
 4 11 (12%) 
Location of ulceration   
  Proximal 62 (69%) 
  Distal 28 (31%) 
Data are number (percentage).  
- 40 - 
 
Table 2 shows the plaque surface morphology characteristics of the 448 carotid arteries with 
atherosclerotic plaque. We found 90 ulcers in 73 carotid arteries of 61 patients. Both carotid 
arteries were ulcerated in 12 patients, and some patients had multiple (up to 4) ulcerations in 
the same carotid artery. The prevalence of ulceration among the patients with at least one 
atherosclerotic carotid artery (n=258) was 24%. Most of the ulcerations (69%) were located 
proximal to the point of maximum stenosis, and ulcer Type 1 and ulcer Type 3 were most 
frequently observed. An irregular plaque was demonstrated in 22% of the carotid arteries with 
atherosclerotic disease. The 2 observers agreed on the presence of complicated plaque in 
93% of the cases (kappa=0.84; 95% CI, 0.70 to 0.97), on the presence of ulcerated plaque in 
all cases (kappa=1; 95% CI, 0.86 to 1.00), on the location of plaque ulceration in 96% of the 
cases (kappa=0.91; 95% CI, 0.54 to 1.00), and on the types of plaque ulceration in all cases 
(kappa=1; 95% CI, 0.95 to 1.00). 
 
Table 3. Cross-table with the degree of stenosis according to the NASCET criteria compared 
with plaque surface morphology of 448 atherosclerotic carotid arteries. The presence of 
irregular and ulcerated plaques is significantly different between the lowest degree of stenosis 
(0-29%) and the higher degrees of stenosis (30-99%) (p-value for both <0.001). 
 Number of carotids Smooth Irregular Ulcerated 
0% - 29% 346 265 (77%) 49 (14%) 32 (9%) 
30% - 49% 48 8 (17%) 23 (48%) 17 (35%) 
50% - 69% 29 1 (3%) 13 (45%) 15 (52%) 
70% - 99% 25 2 (8%) 14 (56%) 9 (36%) 
Total 448 276 99 73 
Data are number (percentage) 
 
Table 3 shows a crosstable with the degree of stenosis compared with the plaque surface 
morphology. It can be observed that ulcerated and irregular plaques are significantly (P<0.001) 
more common and smooth plaques less common among carotid arteries with a higher degree 
of stenosis (30% to 99%). There were not enough ulcerated plaques to determine significant 
differences in the distribution of ulcer type among the different degrees of stenosis. 
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Table 4. A. The multivariable adjusted odds ratios for associations between the complicated 
carotid plaques and cardiovascular risk factors for all patients with atherosclerosis (n=258). B. 
The multivariable adjusted odds ratios for associations between the ulcerated carotid plaques 
and cardiovascular risk factors for all patients with atherosclerosis (n=258). In both analyses 
the most severe stenosis per patient and the most severe plaque surface morphology per 
patient was used.  
A. Complicated plaque Odds ratio (95% CI) P-value 
Age (per increasing decade) 1.1 (0.8-1.5) 0.50 
Gender 1.1 (0.5-2.3) 0.88 
Previous cerebrovascular disease 1.8 (0.9-3.7) 0.12 
Previous cardiac disease 0.8 (0.4-1.7) 0.55 
Hypertension 0.9 (0.4-2.3) 0.87 
Hypercholesterolemia 3.0 (1.0-8.9) <0.05 
Diabetes 0.6 (0.2-1.9) 0.43 
Smoking 1.9 (0.9-4.1) 0.09 
Degree of stenosis (per 10% increase) 2.3 (1.9-2.9) <0.001 
B. Ulcerated plaque 
Variable Odds ratio (95% CI) P-value 
Age (per increasing decade) 1.0 (0.7-1.4) 0.92 
Gender 1.2 (0.6-2.6) 0.61 
Previous cerebrovascular disease 1.0 (0.5-2.0) 0.94 
Previous cardiac disease 0.8 (0.4-1.6) 0.52 
Hypertension 0.9 (0.4-2.2) 0.27 
Hypercholesterolemia 0.9 (0.4-2.2) 0.89 
Diabetes 0.5 (0.2-1.4) 0.21 
Smoking 1.6 (0.8-3.3) 0.23 
Degree of stenosis (per 10% increase) 1.5 (1.4-1.8) <0.001 
Data are OR (95% CI).  
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The OR for the association between complicated plaques and severity of stenosis (per 10% 
increase) adjusted for age and gender is 2.3 (95% CI, 1.9 to 2.9). The OR for the association 
between ulcerated plaques and severity of stenosis (per 10% increase) adjusted for age and 
gender is 1.5 (95% CI, 1.3 to 1.7). 
The multivariable adjusted ORs for the association between cardiovascular risk factors and 
complicated plaque in one of the carotid arteries with at least atherosclerotic disease in one of 
the carotid arteries (n=258) are shown in Table 4. A significant association was found with 
hypercholesterolemia (OR, 3.0; 95% CI, 1.0 to 8.9) and a trend toward an association with 
smoking (OR, 1.9; 95% CI, 0.9 to 4.1).  
The multivariable analysis for the association between cardiovascular risk factors and plaque 
ulceration in one of the carotid arteries showed no significant association between 
cardiovascular risk factors and plaque ulceration. 
 
Table 5. Plaque surface morphology in symptomatic and asymptomatic carotid arteries 
stratified for cerebrovascular symptoms. 
 Cerebrovascular symptoms 
Total Amaurosis 
fugax 
TIA / Minor 
stroke 
Symptomatic carotid artery (ipsilateral) 350 83 267 
 
Atherosclerotic plaque (%) 193 (55%) 39 (47%) 154 (58%) 
 
Complicated plaque (%) 89 (25%) 14 (17%) 75 (28%) 
Asymptomatic carotid artery (contralateral) 458 83 267 
 
Atherosclerotic plaque (%) 255 (56%) 41 (49%) 155 (58%) 
 
Complicated plaque (%) 83 (18%) 14 (17%) 54 (20%) 
For patients with vertebrobasilar symptoms both carotid arteries were considered 
asymptomatic. Symptomatic vs. asymptomatic complicated plaque for all patients: p = 0.01; 
Symptomatic vs. symptomatic complicated plaque surface for patients with TIA or minor stroke: 
p =0.03. 
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Table 5 shows that atherosclerotic plaques were present in both symptomatic and 
asymptomatic carotid arteries (55% versus 56%). Symptomatic carotid arteries more often 
harbored complicated plaques than asymptomatic carotid arteries (25% versus 18%, P=0.01, 
respectively). However, multivariable analysis showed that this can be attributed to the 
significantly higher degree of stenosis present in symptomatic arteries compared with 
asymptomatic arteries (P<0.01). 
Complicated plaques were less often observed among patients with amaurosis fugax (17%) 
compared with patients with focal cerebral ischemia (28%); moreover, in the patients with 
amaurosis fugax, symptomatic arteries were not more often complicated than asymptomatic 
arteries (17% versus 17%) as opposed to patients with focal cerebral ischemia (28% versus 
20%; P=0.03). Nonetheless, also in patients with focal cerebral ischemia, the difference in 
incidence of complicated plaques was attributable to the significantly higher stenosis degree 
present in symptomatic arteries. 
 
Discussion 
This study demonstrates that MDCTA can assess atherosclerotic carotid plaque surface 
morphology with differentiation between smooth, irregular, and ulcerated surfaces. It shows 
that the majority of ulcerations are located proximally to the maximum stenosis and that 
ulcerated and irregular plaques are more frequently encountered with a higher degree of 
stenosis. Of all cardiovascular risk factors, hypercholesterolemia was associated with 
complicated plaque, whereas smoking showed a trend toward an association with complicated 
plaque. Finally, it was shown that complicated plaque is more common in the symptomatic 
artery of patients with cerebrovascular symptomatology than in the asymptomatic artery; 
however, this can be ascribed to the significantly higher stenosis degree present in 
symptomatic arteries compared with asymptomatic arteries. 
The present study found ulceration in 11% of the symptomatic carotid artery and in 40% of the 
carotid arteries with a moderate to severe degree of stenosis (30% to 99%). The proportion of 
ulcerated plaques is lower in high-grade stenosis (70% to 90%) compared with 50% to 69% 
stenosis. The difference is not statistically significant but it might indicate a real difference for 
which we have 2 possible explanations: (1) with severe stenosis, calcifications are larger, 
which hampers identification of ulcerations with MDCTA; and (2) the risk of rupture might differ 
with plaque composition, which may change with increasing severity of stenosis. Plaques with 
a moderate stenosis degree have a larger proportion of lipid, whereas plaques with severe 
stenosis are more calcified. 
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Based on the DSA data of the European Carotid Surgery Trialists (ECST) study, Lovett et al. 
reported a prevalence of ulceration of 14% in 3007 symptomatic carotid arteries in patients 
with TIA or minor stroke, and a prevalence of 18% for symptomatic carotid arteries with a 
stenosis >30%.9 In the NASCET study, ulcerations were found in 35% of symptomatic carotid 
arteries with a stenosis >70%.3 In the present study, complicated plaque was present in 89% 
of the carotid arteries with stenosis >30%, which exceeds the reported frequency (63%) of 
carotid plaque surface abnormality detected with DSA.4 The discrepancy in the frequencies of 
ulceration with MDCTA and DSA can be explained by the higher sensitivity of MDCTA in the 
detection of ulcerations; MDCTA has a reported sensitivity of 60% to 94%, whereas DSA has 
a sensitivity of 46% to 69%.4,11,13-15 The lower sensitivity for DSA might be a result of the limited 
viewing directions (usually 2). Besides MDCTA and DSA, MR angiography has been used for 
the assessment of atherosclerotic carotid plaque surface morphology. One study made a 
comparison between these techniques and concluded that luminal surface irregularities were 
most frequently seen at CTA and that with CTA and MR angiography, more ulcerations were 
detected than with DSA.13 Saba et al. have recently showed that ultrasound has a high 
specificity (93%) but a low sensitivity (38%) for the detection of carotid ulceration, which is in 
concordance with previous studies. 15,20,21 The low sensitivity can be ascribed, in part, to the 
fact that acoustic shadowing from calcifications obscures the presence of ulcerations. 
A recent histological study of symptomatic carotid endarterectomy specimens from 526 
consecutive patients with a stenosis degree of 75% to 90% found ulceration in 58% of the 
specimens.22 The discrepancy in the frequencies of ulceration between MDCTA and histology 
in patients with a severe degree of stenosis can be explained by the higher resolution of 
histology, which enables the detection of small ulcerations, and the higher volume of 
calcifications in severe stenosis, which hampers accurate detection of small ulcerations by 
MDCTA. In addition, thrombus formation on the location of a rupture may fill the ruptured site, 
which will lead to nonvisualization with MDCTA. 
Lovett et al8 characterized ulcerations as Type 1 to 4 and determined that Type 1 and Type 3 
are the most frequent type of rupture; the present study confirms these findings. However, the 
categorization of ulcers is only important when their occurrence can be related to different 
clinical behavior; this has not yet been demonstrated. 
Ulcerations were most frequently seen at the proximal site of the maximum stenosis. The 
ECST data revealed the same distribution of ulcer location in the carotid artery (71% at the 
proximal site) as in the present study.9 An intracoronary ultrasound study found that 69% of 
the ulcerated ruptured plaques (80%) were proximal to the minimal lumen site.23 The proximal 
site as a predilection site for ulceration is in concordance with shear stress theories. It is 
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thought that high shear stress on the plaque surface (due to the lumen narrowing) weakens 
the cap through numerous signaling pathways.10 Indeed, in a recent case report, Groen et al. 
showed in a serial MRI study that the ulceration was located at the high shear stress region.24 
Shear stress may therefore play an important role in the rupture of plaques. 
The present study showed that plaque ulceration is not only present in high-grade stenosis, 
but can also occur in hemodynamically insignificant stenosis. A similar observation was made 
on the ECST data.4 Most of the patients with an ischemic stroke did not have severe stenosis 
despite the accumulation of a substantial amount of atherosclerotic plaque in the carotid 
bifurcation. Detection of plaque ulceration thereby provides a clue to the underlying 
pathophysiology of the previously occurring ischemic stroke; rupture of the plaque may have 
been accompanied by thrombus formation and embolization of plaque material or thrombus 
into the intracranial circulation. In addition, detection of plaque ulceration indicates that a 
patient has an increased risk of a new ipsilateral ischemic stroke.4 Whether surgical or 
endovascular intervention in symptomatic patients without significant stenosis but with plaque 
ulceration is justified remains to be demonstrated in larger prospective studies. Ideally, these 
studies should use the noninvasive imaging tools that are currently available. 
In the present study, hypercholesterolemia is positively and significantly associated with the 
presence of complicated plaques, whereas smoking had a positive (but not significant) 
association with the presence of complicated plaques. Previous studies with univariate 
analysis revealed associations between irregular plaques and gender, age, carotid stenosis, 
hypercholesterolemia, and previous myocardial infarction.3,4 Because irregular plaques are 
related to the severity of stenosis, multivariable analysis with adjustment for the severity of 
stenosis is necessary to demonstrate whether certain cardiovascular risk factors are 
independently related to the presence of irregular plaques. 
The association with hypercholesterolemia might be explained by the atherogenic effect of 
lipoprotein(a) in the presence of high plasma low-density lipoprotein cholesterol levels, which 
increases lipid deposition in atherosclerotic plaque,25,26 making the plaque probably more 
vulnerable for rupture. Cigarette smoking is considered to influence inflammation and 
hemostasis in such a way that plaque inflammation and thrombogenicity increases with cap 
degradation, plaque rupture, and subsequent thrombus formation as a possible result.27 
In the present study, ulcerated and irregular plaques are significantly more common in the 
ipsilateral symptomatic carotid artery than in the asymptomatic carotid artery, which is in line 
with the findings of Sitzer et al, who concluded that plaque ulceration is more common in 
carotid endarterectomy specimens from symptomatic arteries than from asymptomatic 
arteries.28 However, multivariate analysis showed that this difference does not remain 
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significant when severity of stenosis was added to the model. This indicates that besides local 
factors like plaque composition or shear stress, also systemic factors are important in the 
occurrence of plaque rupture. A reasoning that is supported by the findings of Rothwell et al, 
who reported that patients with irregular plaque in the symptomatic carotid artery were more 
likely to have irregular plaques in the contralateral artery, and by a study from Fisher et al, 
which concluded that plaque ulceration was more common in symptomatic patients than in 
asymptomatic patients but that the prevalence of ulceration in the ipsilateral and contralateral 
carotid artery in symptomatic patients was the same. 29,30 
Although the recent paper by Saba et al15 showed that MDCTA is an excellent technique to 
evaluate carotid ulceration, we realize that it is a limitation of our study that we do not have a 
gold standard (e.g., histological specimens). Unfortunately, correlation with histological results 
is troublesome, because only patients with severe stenosis (NASCET >70% stenosis) are 
eligible for intervention, which in our hospital includes stenting in approximately 50% of the 
cases. Therefore, it is not possible to obtain histology from a vast majority of patients. 
A second limitation of our study is its cross-sectional design. The evaluation of the causal 
association between severity of stenosis and complicated plaques, between cardiovascular 
risk factors and complicated plaques, and between complicated plaques and ischemic 
cerebrovascular disease requires a prospective design in which the atherosclerotic plaque is 
evaluated serially to detect changes in plaque surface morphology.  
 
Conclusion 
This study shows that MDCTA can classify atherosclerotic carotid plaque surface morphology. 
Furthermore, it shows that the presence of a complicated plaque surface in an atherosclerotic 
plaque is strongly related with the severity of stenosis and that the site of ulceration is mostly 
proximal to the most stenotic site. In addition, it is shown that hypercholesterolemia and 
probably smoking are related to the presence of complicated plaques.
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Atherosclerotic plaque ulceration in the 
symptomatic internal carotid artery is associated 
with non-lacunar ischemic stroke 
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Background and Purpose: Atherosclerotic carotid plaque ulceration is considered a marker of 
previous plaque rupture and subsequent thromboembolism, and can be accurately detected with 
multidetector computed tomography angiography (MDCTA). We hypothesized that atherosclerotic 
plaque ulceration is associated with non-lacunar ischemic stroke rather than lacunar stroke. 
Methods: Prospectively, 750 consecutive patients with transient ischemic attack (TIA) or ischemic 
stroke symptoms in the anterior cerebral circulation were evaluated for the presence of 
atherosclerotic plaque ulceration in the symptomatic carotid artery with MDCTA. Patients with stroke 
due to cardiac embolism or other specific etiologies, and patients with amaurosis fugax were 
excluded. Ischemic strokes in the remaining 534 patients were classified as non-lacunar or lacunar 
based on clinical symptoms and MDCT of the brain. Ulceration was defined as extension of contrast 
material beyond the vascular lumen into the surrounding plaque.  
Results: Plaque ulceration in the symptomatic carotid artery was more common in non-lacunar 
strokes (n=47, 20%) as compared to lacunar strokes (n=20, 7%) (P<0.001). After adjustment for 
age, sex, cardiovascular risk factors and degree of stenosis, ulcerations were independently 
associated with non-lacunar stroke, compared to lacunar stroke (OR 2.70, 95% CI 1.43-5.09).  
Conclusions: Atherosclerotic carotid plaque ulceration is associated with non-lacunar ischemic 
stroke, independent of the degree of carotid stenosis. These results suggest that non-lacunar stroke 
and lacunar stroke are caused by different pathophysiological mechanisms.  
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Introduction 
Whereas lacunar strokes are associated with local occlusive disease of the deep perforating arteries 
at the base of the brain,1 large deep and non-lacunar ischemic strokes are frequently caused by 
thromboembolism from extracranial arteries or the heart.2 However, no striking differences have 
been reported in cardiovascular risk profiles of these two stroke subtypes. Nonetheless, atrial 
fibrillation and carotid stenosis are both more common in non-lacunar stroke.3 
Atherosclerotic carotid plaque ulceration is considered to be a marker of previous plaque rupture 
and an influential predictor of ischemic stroke besides degree of stenosis.4,5 Plaque rupture with 
subsequent thrombus formation and embolization of plaque material or thrombus into the intracranial 
circulation may cause non-lacunar stroke. However, it is not known whether carotid plaque ulceration 
is more associated with non-lacunar stroke than with lacunar stroke.  
Multidetector computed tomography angiography (MDCTA) has been demonstrated to be effective 
in the detection of carotid plaque ulceration with a sensitivity and specificity of 94% and 99% 
respectively.6 CT angiography is superior to digital subtraction angiography in detecting ulcerations 
of the carotid atherosclerotic plaque.7 
In the current study, the association between atherosclerotic plaque ulceration in the symptomatic 
carotid artery and non-lacunar stroke was evaluated by means of MDCTA in a large population of 
patients with ischemic stroke. 
 
Materials and Methods 
 
Study Population 
From a prospective registry of 911 patients with amaurosis fugax, transient ischemic attack (TIA) or 
minor ischemic stroke (Rankin score <4) who did undergo a MDCTA of the carotid artery we selected 
all patients (n=750) with symptoms in the anterior circulation. Patients were enrolled from a 
specialized TIA/stroke outpatient clinic or the neurology ward. All patients underwent an interview, 
neurological examination, electrocardiography and laboratory analysis on admission. Medical history 
and cardiovascular risk factors were thereby recorded. On admission, patients underwent MDCT of 
the brain and MDCTA of the carotid arteries in a single session. In 3 patients the carotid artery could 
not be analyzed on MDCTA due to scan artifacts. Patients with a likely cardiac etiology (n=96) or 
other specific etiology according to the TOAST criteria (n=20) were excluded.8 Patients with 
amaurosis fugax (n=79) were subsequently excluded as amaurosis fugax is associated with several 
non-vascular etiologies.9 The remaining 534 patients were included in the study. 
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Cardiovascular Risk Factors  
Hypercholesterolemia was defined as fasting cholesterol >5.0 mmol/l, or treatment with cholesterol-
lowering medication. Hypertension was defined as a systolic blood pressure >140 mmHg and/or a 
diastolic blood pressure >90 mmHg, during two episodes of at least 15 minutes of continuous non-
invasive blood pressure measurement or treatment with antihypertensive medication. Diabetes was 
defined as fasting serum glucose levels >7.9 mmol/l, HbA1c >6.5%, or use of antidiabetic 
medication.  
 
MDCT and MDCTA Data Acquisition 
Imaging was performed with a 16-slice MDCT scanner (Siemens, Sensation 16, Erlangen, Germany) 
or a 64-slice MDCT scanner (Siemens, Sensation 64, Erlangen, Germany) with a standardized 
optimized contrast-enhanced protocol (120 kVp, 180 mAs, collimation 16 x 0.75 mm or 64 x 0.6 mm, 
pitch ≤1).10,11  
The MDCT brain scan ranged from the foramen magnum to the vertex. Image reconstructions were 
made with a 220 mm field of view, matrix size 512 x 512, (real in-plane resolution 0.5 x 0.5 mm), 
slice thickness 3 to 4.5 mm and with an intermediate reconstruction algorithm. 
The MDCTA scan ranged from the ascending aorta to the intracranial circulation (2 cm above the 
sella turcica). All patients received 80 ml contrast material (Iodixanol 320 mg/ml, Visipaque, 
Amersham Health, Little Chalfont, UK), followed by a 40 ml saline bolus chaser, both with an injection 
rate of 4 ml/sec. Synchronization between the passage of contrast material and data acquisition was 
achieved by real time bolus tracking at the level of the ascending aorta. Image reconstructions were 
made with a 100 mm field of view, matrix size 512 x 512 (real in-plane resolution 0.6 x 0.6 mm), slice 
thickness 1.0 mm, increment 0.6 mm and with an intermediate reconstruction algorithm.12  
 
MDCT and MDCTA Data Analysis 
Relevant cerebral infarctions on MDCT of the brain related to the stroke symptoms were classified 
as non-lacunar infarction or lacunar infarction. A non-lacunar infarction was defined as an infarction 
with involvement of the cerebral cortex or a large deep infarction > 1.5 cm. A lacunar infarction was 
defined as an infarction in the deep brain structures (grey or white matter) with a size ≤ 1.5 cm.  
The MDCTA images were sent to a stand-alone workstation (Leonardo – Siemens Medical Solutions, 
Forchheim, Germany) with dedicated 3D analysis software for further analysis. The symptomatic 
carotid bifurcation was evaluated with multi-planar reformatting (MPR) software. Herewith, oblique 
planes were adjusted to evaluate the carotid bifurcation in multiple reformations in the short axis and 
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long axes with respect to the carotid artery. Two experienced investigators blinded to clinical data 
and MDCT of the brain analyzed the MDCTA images. Discrepancies were solved by consensus. 
Firstly, the degree of stenosis in the symptomatic carotid artery was determined according to the 
North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria.13 Secondly, the 
symptomatic carotid artery was evaluated for the presence of occlusion, atherosclerotic plaque and 
atherosclerotic plaque ulceration. Presence of atherosclerotic plaque was defined as thickening of 
the vessel wall and/or the presence of calcification. Plaque ulceration was defined as extension of 
contrast media beyond the vascular lumen into the surrounding plaque.  
 
Stroke Type and Etiology 
All patients were analyzed for ischemic stroke etiology. The presence of a likely cardiac etiology or 
other specific etiology according to the TOAST criteria was determined.8 The remaining patients 
were classified as having a non-lacunar stroke, lacunar stroke or amaurosis fugax based on clinical 
symptoms and findings on MDCT of the brain. Non-lacunar ischemic stroke was defined as a) ≥ two 
of following symptoms: 1. higher cerebral dysfunction (e.g. dysphasia, dyscalculia, visuospatial 
disorder), 2. homonymous visual field defect and 3. ipsilateral motor and/or sensory deficit or b) 
higher cerebral dysfunction alone and/or, a motor or sensory deficit more restricted than those 
classified as lacunar (e.g. confined to one limb, face and/or hand but not the complete arm). Lacunar 
ischemic stroke was defined as a pure motor stroke, pure sensory stroke, sensory-motor stroke, 
dysarthria clumsy hand syndrome, or ataxic hemiparesis without brainstem symptoms.14 Amaurosis 
fugax was defined as a sudden, loss of vision that was presumed to be of vascular origin and 
confined to one eye. 
 
Statistical Analysis 
Data are presented as means ± SD or number of patients (%). Differences between categorical data 
were analyzed with a Chi-square test or Fisher's Exact Test where appropriate. Differences between 
continuous data were analyzed with a Mann-Whitney test. The association between degree of 
stenosis and plaque ulceration was evaluated in a multivariable logistic model adjusted for age and 
sex. The association between age, sex, cardiovascular risk factors, degree of stenosis (per 10% 
increase) and plaque ulceration with non-lacunar stroke (with lacunar stroke as reference) was first 
evaluated in a univariable logistic regression model. Thereafter, a multivariable logistic regression 
analysis was performed to identify variables independently associated with non-lacunar stroke. 
Patients with a symptomatic occluded carotid artery, wherein assessment of atherosclerotic plaque 
morphology was not possible, were not included in this analysis. 
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A multivariable logistic regression analyses was repeated with non-lacunar infarctions (versus 
lacunar infarctions) on MDCT of the brain to confirm the association of plaque ulcerations with 
clinically defined stroke subtype. 
Statistical analyses were performed using SPSS software (version 15.0, Inc., Chicago, Illinois). P-




Patients Characteristics  
Excluded patients with a likely cardiac etiology or other specific etiology (n=116) had less 
hypertension (56% versus 71%, P=0.002) and smoked less often (28% versus 39%, P=0.02) than 
patients included in the analysis. In this group, plaque ulceration in the symptomatic carotid artery 
was present in 9 patients (8%). Excluded patients with amaurosis fugax (n=79) smoked less often 
(28% versus 39%, P=0.04) and had less often a previous ischemic stroke (5% versus 14%, P=0.02) 
than included patients. Plaque ulceration in the symptomatic carotid artery was present in 7 patients 
(7%) with amaurosis fugax.  
In the remaining 534 patients, non-lacunar stroke was present in 236 patients and lacunar stroke in 
298 patients. Baseline characteristics of patients with non-lacunar and lacunar stroke are illustrated 
in table 1. The mean age of the study population was 62±13 years and 56% of the patients were 
male. Patients with non-lacunar stroke were significantly older than patients with lacunar stroke (64 
versus 61 years, P=0.003). The prevalence of other cardiovascular risk factors was similar in the two 
groups. 
 
Plaque Surface Morphology in the Symptomatic Carotid Artery 
In 362 of the 534 patients (68%) atherosclerotic plaque was observed in the symptomatic carotid 
artery. In 23 patients (4%), the symptomatic carotid artery was occluded and in 149 patients (28%) 
the symptomatic carotid artery was normal. Plaque ulcerations were observed in 67 symptomatic 
carotid arteries (13%). The prevalence of ulcerations in symptomatic carotid arteries with 
atherosclerotic plaque was (19%).  
The likelihood of plaque ulceration in the symptomatic carotid artery was increased with a higher 
degree of stenosis after adjustment for age and gender (OR 1.6, 95% CI 1.4-1.7). 
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n=298 (56%) P-value 
Age (years) 64±13 61±13  0.003 
Male Sex 128 (54%) 170 (57%) 0.52 
Hypercholesterolemia 174 (74%) 215 (72%) 0.68 
Hypertension 167 (71%) 212 (71%) 0.92 
Diabetes Mellitus 50 (21%) 55 (18%) 0.43 
Smoking  82 (35%) 126 (42%) 0.08 
Peripheral Arterial Disease 17 (7%) 17 (6%) 0.48 
Previous Ischemic Stroke 31 (13%) 42 (14%) 0.75 
Previous TIA  36 (15%) 42 (14%) 0.71 
Previous Intracerebral Hematoma 4 (2%) 5 (2%) 0. 99 
History of Ischemic Heart 
Disease 
37 (16%) 42 (14%) 0.61 
Data are medians (lower quartile, upper quartile) or number of patients (%).  
 
Risk Factors for Non-lacunar Ischemic Stroke 
Atherosclerotic plaques in the symptomatic carotid artery were significantly more prevalent in 
patients with non-lacunar stroke as compared to patients with lacunar stroke (72% versus 65%, 
P<0.001). Occlusions of the symptomatic carotid artery were significantly more prevalent in patients 
with non-lacunar stroke as compared to patients with lacunar stroke (8% versus 1%, P<0.001) (table 
2).  
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Table 2. MDCTA Plaque Characteristics of the symptomatic carotid artery in patients with non-







n=298 (56%) P-value 
Atherosclerotic Plaque 169 (72%) 193 (65%) 
<0.001 
 
Occluded carotid artery  19 (8%) 4 (1%) 
Normal carotid artery 48 (20%) 101 (34%) 
    
Degree of Stenosis    
0% 121 (56%) 207 (70%) 
<0.001 
1-29% 38 (18%) 57 (19%) 
30-49% 18 (8%) 17 (6%) 
50-69% 22 (10%) 5  (2%) 
≥70% 18  (8%) 8  (3%) 
    
Plaque Ulceration 47 (20%) 20 (7%) <0.001 
Data are means ± SD or number of patients (%).  
 
Severe stenosis of the symptomatic carotid artery in patients with non-lacunar stroke was 
significantly more prevalent than in patients with lacunar stroke (P<0.001). Plaque ulceration in the 
symptomatic carotid artery was more common in non-lacunar strokes (n=47, 20%) as compared to 
lacunar strokes (n=20, 7%) (P<0.001). In patients with plaque ulcerations no significant differences 
in number of ulcerations per plaque, location of the ulceration and type of ulceration were observed 
between patients with non-lacunar and lacunar stroke.  
Risk factors associated with non-lacunar stroke (as opposed to lacunar stroke) in univariable and 
multivariable analysis are provided in table 3. In univariable analysis age, degree of stenosis and 
plaque ulceration were found to be significantly associated with non-lacunar stroke, whereas 
smoking was found to be associated with lacunar stroke. Risk factors independently associated with 
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non-lacunar stroke in multivariable analysis were degree of stenosis (OR 1.19, 95% CI 1.07-1.32) 
and plaque ulceration (OR 2.70, 95% CI 1.43-5.09).  
 
Table 3. Univariable- and multivariable odds-ratios for association between non-lacunar stroke 







Age (per decade) 1.23 (1.08-1.40) 1.11 (0.96-1.29) 
Male Sex  0.84 (0.59-1.20) 0.70 (0.48-1.02) 
Hypercholesterolemia 1.02 (0.69-1.51) 0.86 (0.56-1.33) 
Hypertension 0.98 (0.66-1.44) 0.75 (0.48-1.15) 
Diabetes Mellitus 1.27 (0.82-1.95) 1.24 (0.77-1.98) 
Smoking  0.68 (0.47-0.98) 0.73 (0.49-1.10) 
Peripheral Arterial Disease 1.04 (0.49-2.19) 0.81 (0.36-1.87) 
Previous Ischemic Stroke 0.89 (0.53-1.49) 0.81 (0.46-1.42) 
Previous TIA  1.17 (0.71-1.94) 1.05 (0.61-1.82) 
Previous Intracerebral Hematoma 1.09 (0.29-4.09) 1.07 (0.27-4.27) 
History of Ischemic Heart Disease 1.23 (0.75-2.00) 1.09 (0.63-1.89) 
Degree of Stenosis (per 10%) 1.27 (1.16-1.40) 1.19 (1.07-1.32) 
Plaque Ulceration 3.79 (2.17-6.61) 2.70 (1.43-5.09) 




- 60 - 
 
As illustrated by the forest plot in figure 1, multivariable analysis revealed an independent association 
between plaque ulceration and non-lacunar stroke after adjustment for age and sex; age, sex and 
cardiovascular risk factors; degree of stenosis alone and age, sex, cardiovascular risk factors and 
degree of stenosis. 
 
Figure 1. Symptomatic carotid plaque ulceration is independently associated with non-lacunar stroke 
after correction for age, sex, cardiovascular risk factors (RF) and degree of stenosis. 
 
Risk Factors for Non-lacunar Infarction on MDCT of the brain  
An infarction on MDCT of the brain was found in 162 patients (30%), including 82 patients with non-
lacunar infarction and 80 patients with lacunar infarction. In patients with non-lacunar infarction as 
compared to patients with lacunar infarction, a higher prevalence of atherosclerotic plaques (n=60, 
73% versus n=65, 81%) and occlusions (n=10, 12% versus n=1, 1%) (P=0.02), were observed in 
the symptomatic carotid artery. Plaque ulceration in the symptomatic carotid artery was more 
common in non-lacunar infarction (n=23, 28%) as compared to lacunar infarction (n=7, 9%) 
(P=0.002).  
5. Adjustment for age & sex & RF & degree of stenosis 
4. Adjustment for degree of stenosis 
3. Adjustment for age & sex & RF 
2. Adjustment for age & sex 






OR = 1 
- 61 - 
 
Risk factors associated with non-lacunar infarction (as opposed to lacunar infarction) in univariable 
and multivariable analysis are provided in table 4. Atherosclerotic plaque ulceration was 
independently associated with non-lacunar infarction in multivariable analysis (OR 4.31, 95% CI 
1.49-12.50). 
 
Table 4. univariable- and multivariable odds-ratios for association between CT confirmed non-
lacunar infarctions (versus lacunar infarctions) and cardiovascular risk factors, degree of stenosis 






Age (per decade) 0.90 (0.69-1.18) 0.80 (0.58-1.09) 
Male Sex 1.16 (0.61-2.20) 0.92 (0.44-1.91) 
Hypercholesterolemia 0.70 (0.32-1.53) 0.75 (0.32-1.77) 
Hypertension 0.60 (0.28-1.31) 0.44 (0.18-1.08) 
Diabetes Mellitus 1.48 (0.72-3.03) 2.01 (0.89-4.50) 
Smoking 0.95 (0.50-1.80) 0.76 (0.36-1.63) 
Peripheral Arterial Disease 0.97 (0.35-2.67) 0.93 (0.29-3.04) 
Previous Ischemic Stroke 1.47 (0.64-3.39) 1.56 (0.60-4.05) 
Previous TIA  0.99 (0.38-2.58) 0.54 (0.17-1.80) 
Previous Intracerebral Hematoma 1.10 (0.07-17.89) 1.48 (0.08-26.23) 
History of Ischemic Heart Disease 1.11 (0.45-2.75) 1.01 (0.34-2.98) 
Degree of Stenosis (per 10%) 1.23 (1.05-1.44) 1.19 (0.98-1.46) 
Plaque Ulceration 4.83 (1.92-12.12) 4.31 (1.49-12.50) 
Data are OR (95% CI).  
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Discussion  
In the current study patients with ischemic cerebrovascular symptoms were classified according to 
presumed stroke etiology. Besides degree of stenosis, atherosclerotic carotid plaque ulceration was 
shown to be independently associated with non-lacunar stroke. This relation between plaque 
ulceration and clinically defined non-lacunar stroke was confirmed by an independent association 
between the presence of atherosclerotic carotid plaque ulceration and non-lacunar infarction on 
MDCT of the brain.  
 
Etiology of ischemic stroke subtypes 
The association of various risk factors with subtypes of ischemic stroke has been studied 
extensively.3 Differences in cardiovascular risk factor profile would support a distinct arterial 
pathological process underlying different types of stroke. Previous studies had suggested lacunar 
strokes to be predominantly associated with hypertension and diabetes mellitus.15,16 
However, in a recent review by Jackson and colleagues, only a marginal increase was shown in the 
prevalence of hypertension in patients with lacunar stroke as compared to non-lacunar stroke.3 
Whereas no difference was observed in the prevalence of diabetes mellitus. The authors suggested 
that the previously observed difference in risk factors between ischemic stroke subtypes was based 
on stroke classification bias, as most studies included risk factors in their ischemic stroke subtype 
definitions. In the present study, a risk factor free stroke subtype classification was used. Thereby, 
we differentiated between non-lacunar and lacunar ischemic stroke based on clinical symptoms and 
MDCT imaging of the brain. In concordance with Jackson et al, no significant difference in 
cardiovascular risk factors was observed between patients with non-lacunar and lacunar ischemic 
stroke. To further elucidate the pathophysiological mechanisms associated with subtypes of 
ischemic stroke we therefore evaluated the relation between parameters of carotid atherosclerosis 
as assessed by MDCTA of the symptomatic carotid artery. 
 
Relation of Carotid Artery Stenosis and Plaque Ulceration with Non-lacunar Stroke  
The relation of degree of stenosis and plaque ulceration with any ischemic stroke has been 
previously studied using conventional angiographic studies. Previous studies relating degree of 
stenosis with specific stroke subtypes have identified an association with non-lacunar stroke.3,17,18 
Accordingly, in the current study a significant relation was observed between the severity of carotid 
stenosis and presence of non-lacunar stroke. Plaque ulceration in the symptomatic carotid artery of 
patients with ischemic stroke has been shown to be independently associated with an increased risk 
of recurrent ipsilateral ischemic stroke in patients on medical treatment in the NASCET and ECST 
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study.4,5 However, no previous studies have evaluated the association of plaque ulceration with non-
lacunar stroke in particular.  
Atherosclerotic carotid plaque ulcerations are thought to be a marker of previous plaque ruptures.19 
Following plaque rupture, thrombogenic material is exposed to blood initiating platelet aggregation 
and thrombus formation, ultimately leading to thromboembolism or local carotid artery occlusion.20 
Emboli from ruptured atherosclerotic carotid plaques may occlude the intracranial cerebral arteries, 
resulting in ischemia of cortical and subcortical brain tissue. Accordingly, Lovett et al. observed a 
strong correlation between atherosclerotic plaque ulceration in the carotid artery and histological 
characteristics of plaque instability including plaque rupture, intraplaque hemorrhage and large lipid 
core.21 The results of the present study support this underlying mechanism by revealing an 
independent association between plaque ulceration in the symptomatic carotid artery and non-
lacunar stroke. In addition, current results suggest a different pathophysiological mechanism in non-
lacunar and lacunar stroke subtypes.  
 
Clinical and Research Implications 
Recent research on atherosclerosis has shifted from severity of stenosis towards parameters of 
plaque vulnerability. Plaque surface morphology and plaque ulcerations may reflect plaque 
vulnerability. Plaque surface evaluation of the symptomatic carotid artery has been recommended 
in an algorithm for clinical decision making concerning carotid endarterecomy.22 That particular 
algorithm is based on the results of the NASCET and ECST data wherein plaque surface morphology 
was evaluated using conventional arterial angiography. However, in current clinical practice 
conventional angiography is increasingly replaced by non-invasive imaging modalities such as 
MDCTA and magnetic resonance angiography (MRA). Both techniques provide accurate non-
invasive evaluation of carotid artery stenosis. In addition, MDCTA provides supplementary 
information on plaque surface morphology as compared to MRA.7 Accordingly, for individual risk 
stratification assessment of plaque surface morphology could be based on MDCTA rather than 
conventional angiography.  
The predominant association of plaques ulcerations with the presence of non-lacunar ischemic 
stroke in the current study suggests that risk stratification strategies using plaque ulceration should 
be developed with caution and potentially adjusted for type of clinically defined ischemic stroke. 
Furthermore, future studies relating atherosclerotic disease to clinical events or brain tissue damage 
should therefore take the heterogeneity of stroke etiologies into account. 
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Study Limitations  
Firstly, the current study is based on carotid analysis by MDCTA, and findings were not confirmed 
by histological specimens. However, MDCTA has been validated for detection of plaque 
ulceration.6,23 The applied stroke subtype classification was based on clinical symptoms and 
corrected for relevant infarctions seen on MDCT of the brain. Although a clinical approach results in 
an accurate classification in the majority of patients, some misclassifications are inevitable. 
Nonetheless, after replication of the analysis based on infarctions alone as a substitute for clinically 
defined stroke subtypes, the independent association between carotid plaque ulceration and non-
lacunar infarction was confirmed. Finally, the present study has a cross-sectional design. Therefore, 
the prognostic value of carotid plaque ulcerations in different stroke subtypes remains to be 
determined in follow-up studies. Also, the incremental value of medical treatment adapted for plaque 
morphology needs to be determined in a randomized clinical study.24 
 
Conclusion  
Atherosclerotic plaque ulceration of the symptomatic carotid artery is strongly related with non-
lacunar ischemic events as compared to lacunar ischemic events, independently of severity of 
stenosis. This finding was confirmed by an independent association between the presence of 
atherosclerotic carotid plaque ulceration and non-lacunar infarctions on MDCT of the brain. These 
results indeed suggest that non-lacunar ischemic stroke and lacunar stroke are caused by different 
pathophysiological mechanisms. Plaque ulceration is an important factor to evaluate in future 
prognostic and therapeutic studies of patients with carotid atherosclerotic disease. 
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Background and Purpose: Symptomatic carotid artery plaque ulceration is associated with distinct 
plaque components such as a large lipid-rich necrotic core (LR-NC) in ischemic stroke patients with 
a ≥50% carotid stenosis. We evaluated the associations between carotid artery plaque ulceration 
and plaque characteristics in ischemic stroke patients with ≥50% stenosis as well as in those with a 
low degree stenosis (0-49%).  
Methods: Consecutive patients (n=346) with symptoms in the anterior circulation were evaluated 
with multi-detector CT angiography (MDCTA) for the presence of atherosclerotic plaque, degree of 
stenosis, and plaque ulceration in the symptomatic carotid artery. Plaque volume and plaque 
component proportions of LR-NC, fibrous tissue, and calcification were measured. The associations 
between plaque ulceration and plaque characteristics were analyzed using logistic regression. 
Results: Atherosclerotic plaque was present in 185 patients. Plaque ulcerations were present in 38 
(21%) patients, of which half had a low degree stenosis (0-49%). Plaque volume was significantly 
larger in ulcerated plaques. After adjustment for age, sex, and degree of stenosis, LR-NC proportion 
was strongly associated with plaque ulceration (OR 2.21; 95%CI 1.49-3.27), whereas calcification 
proportion was inversely associated with plaque ulceration (OR 0.60; 95%CI 0.40-0.89). These 
associations remained significant in patients with a low degree stenosis (0-49%). 
Conclusion: Plaque volume, degree of stenosis, and LR-NC proportion evaluated non-invasively 
with MDCTA are associated with carotid artery plaque ulceration, even in patients with a low degree 
stenosis (0-49%). Plaque volume and composition analysis with MDCTA may identify rupture prone 
plaques, and improve risk stratification in ischemic stroke patients. 
 
- 69 - 
 
Introduction 
Atherosclerotic carotid plaque ulceration is an independent marker of previous plaque rupture and 
an influential predictor of ischemic stroke.1,2 Thus far, histological and non-invasive imaging 
assessment of the relation of carotid plaque characteristics with plaque surface disruption has been 
limited to patients with a ≥50% carotid stenosis.3,4 In patients with severe symptomatic stenosis, 
carotid plaque ulceration has been associated with the presence of fibrous cap rupture and distinct 
plaque components such as intraplaque hemorrhage, large lipid core, and less fibrous tissue.3 
However, a ≥50% carotid stenosis is present in only approximately 10% of patients with amaurosis 
fugax, transient ischemic attack or minor ischemic stroke.5 Whereas two-third of carotid plaque 
ulcerations is observed in carotid arteries with a low degree stenosis (0-49%),6 little is known about 
the relation between carotid plaque characteristics with plaque ulceration in these patients. Also, 
limited data are available on the association between plaque volume and carotid plaque surface 
disruption.4 
Analysis of atherosclerotic plaque volume and plaque composition using non-invasive imaging could 
be useful to identify rupture prone plaques. However, concomitant assessment of carotid plaque 
characteristics associated with plaque rupture cannot be advocated in the general population of 
ischemic stroke patients without knowledge of the relation between plaque characteristics and 
plaque surface disruption. 
In the current study, we analyzed the relationship between the symptomatic carotid plaque 
characteristics, comprising of plaque component proportions and plaque volume, with plaque 
ulceration in consecutive patients with amaurosis fugax, transient ischemic attack or ischemic stroke 
using multi-detector CT angiography (MDCTA). The analysis included and compared the 
associations of plaque characteristics with plaque ulceration in symptomatic carotid arteries with 
significant stenosis (≥50%), as well as in those with a low degree stenosis (0-49%). 
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Materials and Methods 
 
Study Population 
From a prospective registry of 911 consenting patients with amaurosis fugax, transient ischemic 
attack or ischemic stroke (Rankin score <4) who underwent MDCTA of the carotid arteries, we 
selected a two-year cohort of consecutive patients (n=346) with symptoms in the anterior circulation. 
Patients were enrolled from a specialized transient ischemic attack/stroke outpatient clinic or the 
neurology ward. All patients underwent an interview, neurological examination, electrocardiography, 
laboratory analysis, and MDCTA on admission. Medical history and cardiovascular risk factors as 
defined previously were recorded.7 Patients without atherosclerotic plaque (n=137), with carotid 
occlusion (n=20), and patients with an MDCTA of insufficient quality (n=4) were excluded from the 
analysis.  
 
MDCTA Data Acquisition and Data Analysis 
Imaging was performed with a 16-slice MDCT scanner (Sensation 16, Siemens, Erlangen, Germany) 
or a 64-slice MDCT scanner (Sensation 64, Siemens, Erlangen, Germany) with a standardized 
optimized contrast-enhanced protocol (120 kVp, 180 mAs, collimation 16x0.75 mm or 64x0.6 mm, 
pitch≤1).8 Details of the MDCTA scan protocol have been described previously.7,9  
MDCTA images were sent to a stand-alone workstation (Leonardo – Siemens Medical Solutions, 
Forchheim, Germany) with dedicated 3D-analysis software. The symptomatic carotid bifurcation was 
evaluated by two experienced investigators blinded to clinical data with multi-planar reformatting 
software, which allows reconstruction of sagittal, coronal, and oblique views from axial sections. 
Discrepancies were solved by consensus. 
Symptomatic carotid arteries were evaluated for the presence of atherosclerotic plaque, defined as 
thickening of the vessel wall or the presence of calcification. Plaque ulceration was defined as 
extension of contrast media beyond the vascular lumen into the surrounding plaque. Degree of 
stenosis in the symptomatic carotid artery was determined according to the NASCET criteria on 
multi-planar reformatting images perpendicular to the central lumen line.10  
Plaque volume and plaque component proportions were measured with custom-made software, 
programmed in MeVisLab (MeVis Research, Bremen, Germany). Using this software, the 
components of the atherosclerotic plaque within regions of interest drawn on axial MDCTA images 
can be determined from their corresponding Hounsfield values using thresholds determined 
previously.11 The threshold for the distinction between fibrous tissue and lipid-rich necrotic core (LR-
NC) was set at 60 Hounsfield units. The threshold for distinguishing calcifications from fibrous tissue 
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was set at 130 Hounsfield units; the value currently used for calcium scoring. Based on previous 
studies it may be assumed that intraplaque hemorrhage, if present, would be classified as LR-NC or 
fibrous tissue.11,12  
Plaque volume and plaque component volumes were automatically calculated from the number and 
dimensions of voxels for different ranges of Hounsfield unit values within the regions of interest 
(Figure 1). Plaque component proportions were calculated from plaque component volumes as a 
percentage of the plaque volume.  
 
 
Figure 1. Two succeeding axial MDCTA images illustrating an ulcerated plaque in the internal carotid 
artery (left). The plaque composition is visible in the image overlay (right), with LR-NC (yellow), 
fibrous tissue (green), calcifications (white), and the contrast-filled lumen and plaque ulceration (red 
with blue border-zone).  
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Statistical Analysis 
Baseline population and plaque characteristics are presented as mean±SD or number of patients 
(%). Differences were tested with chi-square tests, Fisher's Exact tests or Mann-Whitney tests when 
appropriate. For logistic regression analysis continuous data were divided by 10 or 100, as indicated 
in the relevant tables.  
The correlation between degree of stenosis and plaque volume was evaluated by calculation of the 
Spearman's rank correlation coefficient. The associations between carotid plaque ulceration and 
degree of stenosis, plaque volume, and plaque component proportions were evaluated using logistic 
regression analysis. Two models were constructed. In model I, plaque characteristics were adjusted 
for age and sex. In model II, adjustments were made for age, sex, and degree of stenosis. Finally, 
in a stratified analysis the associations between carotid plaque ulceration and plaque characteristics 
were evaluated in patients with low (0-49%), and with significant (≥50%) carotid stenosis, with 
adjustment for age, sex, and degree of stenosis. P-values ≤0.05 were considered statistically 
significant. All analyses were performed using SPSS 15.0 statistical package for Windows (SPSS, 
INC., Chicago, Illinois, USA). 
 
  




Patients Characteristics  
From the 346 evaluated patients, 185 patients with atherosclerotic plaque were included in all further 
analyses. Baseline characteristics of patients with and without atherosclerotic plaque ulceration in 
the symptomatic carotid artery are illustrated in Table 1. Atherosclerotic plaque ulceration in the 
symptomatic carotid artery was present in 38 (21%) patients. The prevalence of cardiovascular risk 
factors was not significantly different between the two groups.  
 
Table 1. Characteristics of patients with and without symptomatic carotid artery plaque ulceration. 




Patients with  
Plaque Ulceration 
n=38 (21%) 
Patients without  
Plaque Ulceration 
n=147 (79%) P-value 
Age (years) 67±10  67±11 0.74 
Male sex 28 (74%) 93 (63%) 0.26 
Hypercholesterolemia 28 (74%) 124 (84%) 0.15 
Hypertension 27 (71%) 120 (82%) 0.15 
Diabetes mellitus 4 (11%) 30 (20%) 0.24 
Smoking  17 (45%) 45 (31%) 0.10 
Peripheral arterial disease 4 (11%) 15 (10%) 1.00 
Previous ischemic stroke 7 (18%) 19 (13%) 0.43 
Previous TIA  8 (21%) 27 (18%) 0.82 
Previous intracerebral hematoma 2 (5%) 2 (1%) 0.19 
History of ischemic heart disease 7 (18%) 42 (29%) 0.30 
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Plaque Characteristics on MDCTA 
Atherosclerotic plaque characteristics of patients with and without atherosclerotic plaque ulceration 
in the symptomatic carotid artery are illustrated in Table 2. Degree of stenosis was significantly 
higher in patients with plaque ulceration. In patients with carotid artery ulcerations, 19 had 0-49% 
stenosis, whereas the remaining 19 patients had ≥50% stenosis (Figure 2).  
 
 
Figure 2. Bargraph illustrating the degree of stenosis of the symptomatic carotid artery in patients 
with atherosclerotic plaque ulcerations (n=38). 
 
Plaque volume of ulcerated plaques was significantly larger as compared to non-ulcerated plaques. 
A moderate correlation was observed between degree of stenosis and plaque volume (rs=0.57; 
P=0.01). Ulcerated plaques contained a significantly larger LR-NC volume, fibrous tissue volume, 
and LR-NC proportion. Fibrous tissue proportion was significantly lower in ulcerated plaques as 
compared to non-ulcerated plaques. 
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Table 2. Plaque characteristics of patients with and without symptomatic carotid artery plaque 
ulceration. 
Data are means±SD. 
 
Plaque Characteristics associated with Plaque Ulceration on MDCTA 
Results of multivariable analyses relating plaque characteristics and plaque ulcerations are provided 
in Table 3 and 4. After adjustment for age and sex (model I), degree of stenosis, plaque volume, and 
the LR-NC proportion were associated with plaque ulceration, whereas fibrous proportion was 
inversely associated with plaque ulceration. After adjustment for age, sex, and degree of stenosis 
(model II), plaque volume and the LR-NC proportion remained significantly associated with plaque 




Patients with   
Plaque Ulceration 
(n=38; 21%) 
Patients without  
Plaque Ulceration 
(n=147; 79%) P-value 
Degree of Stenosis 44±29% 18±27% <0.001 
Plaque volume 1320±708 mm3 765±588 mm3 <0.001 
LR-NC volume 416±283 mm3 168±197 mm3 <0.001 
Fibrous volume 736±333 mm3 468±306 mm3 <0.001 
Calcification volume 163±178 mm3 129±180 mm3 0.196 
LR-NC proportion  29±10% 18±10% <0.001 
Fibrous proportion  60±11% 67±13% 0.001 
Calcification proportion 10±9% 15±14% 0.152 
- 76 - 
 
Table 3. Multivariable analysis for the associations between symptomatic carotid artery plaque 
ulceration and plaque characteristics.  
 Model I Model II 
 OR (95% CI) P-value OR (95% CI) P-value 
Degree of Stenosis (/10%) 1.33 (1.18-1.50) <0.001 n.a. n.a. 
Plaque volume (/100mm3) 1.14 (1.07-1.21) <0.001 1.09 (1.02-1.16) 0.01 
LR-NC proportion (/10%) 2.58 (1.77-3.78) <0.001 2.21 (1.49-3.27) <0.001 
Fibrous proportion (/10%) 0.64 (0.48-0.87) 0.004 0.85 (0.60-1.20) 0.35 
Calcification proportion (/10%) 0.75 (0.54-1.04) 0.08 0.60 (0.40-0.89) 0.01 
Data are OR (95% CI).  
 
Table 4. Stratified multivariable analysis for the associations between symptomatic carotid artery 
plaque ulceration and plaque characteristics in patients with low (0-49%) and with significant (≥50) 
carotid stenosis.  
 Patients with  
0-49% Stenosis (n=144) 
Patients with  
≥50% Stenosis (n=41) 
 OR (95% CI) P-value OR (95% CI) P-value 
Plaque volume (/100mm3) 1.06 (0.98-1.14) 0.15 1.23 (1.04-1.46) 0.02 
LR-NC proportion (/10%) 3.04 (1.70-5.45) <0.001 1.82 (0.98-3.40) 0.06 
Fibrous proportion (/10%) 0.88 (0.57-1.36) 0.56 1.05 (0.53-2.08) 0.89 
Calcification proportion (/10%) 0.34 (0.16-0.69) 0.003 0.68 (0.40-1.15) 0.15 
Data are OR (95% CI). 
 
In a stratified analysis of patients with a low degree stenosis of 0-49% (n=144), the LR-NC proportion 
remained strongly associated with plaque ulceration, whereas the calcification proportion remained 
inversely associated with plaque ulceration. In patients with significant stenosis of ≥50% (n=41), 
plaque volume was associated with plaque ulceration, whereas a trend towards a significant 
association between the LR-NC proportion and plaque ulceration was observed. 
  
- 77 - 
 
Discussion  
In the current study of patients with amaurosis fugax, transient ischemic attack or ischemic stroke, 
half of the plaque ulcerations were identified in symptomatic carotid arteries with a low degree 
stenosis of 0-49%. Non-invasive carotid artery plaque analysis with MDCTA revealed that degree of 
stenosis, plaque volume, and the LR-NC proportion were associated with plaque ulceration in the 
symptomatic carotid artery. Of these plaque characteristics, the LR-NC proportion was most strongly 
associated with plaque ulceration. In contrast, the calcification proportion was inversely associated 
with plaque ulceration. The observed associations remained significant in patients with a low degree 
carotid stenosis of 0-49%. The current study is the first to evaluate the associations between plaque 
ulceration and plaque characteristics irrespective of the degree of stenosis. 
 
Association of Atherosclerotic Plaque Characteristics with Ischemic Stroke  
Several studies have evaluated the relation of carotid artery plaque characteristics with ischemic 
stroke.13-19 In general, imaging studies with magnetic resonance and CT have identified positive 
associations between fibrous cap thickness, the size of the LR-NC, intraplaque hemorrhage and the 
presence of carotid plaque surface disruption with ischemic stroke in cross-sectional and follow-up 
studies.13-16 Accordingly, in ultrasound studies echolucent carotid plaques were associated with 
increased risk of cerebrovascular events.17,18 Echolucent plaques are known to have higher levels 
of lipid and hemorrhage compared with echogenic plaques, which contain more calcification and 
fibrous tissue. On the contrary, proportion of carotid plaque calcification is shown to be inversely 
associated with the occurrence of ischemic stroke.16,19 However, results of histological analyses have 
been less consistent.20 A review by Golledge et al. demonstrated the lack of an association between 
histologically defined LR-NC and intraplaque hemorrhage with ischemic stroke.20  
The observed discrepancy may be a consequence of disparate etiology of ischemic stroke. 
Nevertheless, plaque rupture and subsequent thrombo-embolism are considered crucial elements 
in the pathophysiological cascade between the development of a heterogeneous plaque and 
thromboembolic stroke.21 As a result, in the present study we evaluated the direct associations 
between plaque characteristics comprising of plaque stenosis, plaque volume and composition with 
plaque ulceration in patients with ischemic stroke. 
 
Association of Atherosclerotic Plaque Characteristics with Carotid Plaque Surface Disruption  
Previous research relating atherosclerotic carotid plaque characteristics with plaque surface 
disruption has focused on stenotic plaques corresponding with luminal narrowing of ≥50%.3,4 In a 
magnetic resonance study, the LR-NC proportion of carotid plaques of ≥50% stenosis was the 
strongest predictor of new surface disruption, in form of an ulceration or a fibrous cap rupture.4 In 
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that particular study, the calcification proportion was inversely related with plaque surface disruption. 
In addition, the presence of intraplaque hemorrhage as assessed with magnetic resonance is 
significantly associated with the presence of plaque ulceration on MDCTA.22 Plaque ulceration on 
conventional angiography in symptomatic carotid arteries with ≥50% stenosis was associated with 
the presence of intraplaque hemorrhage, large lipid core and less fibrous tissue in carotid 
endarterectomy specimens.3 Similarly, ultrasonographic examination of carotid arteries 
demonstrated a relation between echolucency of stenotic plaques and plaque ulceration.23 However, 
conventional angiography and ultrasound provide no quantitative information on plaque volume. 
Therefore, only limited data are available on the relation of plaque volume with plaque surface 
disruption as assessed using magnetic resonance.4  
MDCTA allows fast and reliable evaluation of steno-occlusive disease in extracranial and intracranial  
arteries and is widely available.24-26 The technique is effective in the detection of carotid plaque 
ulceration with a sensitivity and specificity of 94% and 99% respectively.27 Furthermore, distinct 
plaque components as well as plaque volume can be quantified in good correlation with histology.11,12 
In the current study, using MDCTA, the relation between plaque composition and plaque volume 
with plaque ulceration was evaluated in patients with a symptomatic carotid stenosis of ≥50% as well 
as in patients with a low degree of stenosis (0-49%). Interestingly, in line with previous reports, a 
substantial proportion of the plaque ulcerations were located in symptomatic carotid arteries with a 
low degree of stenosis.5,6 The association between the LR-NC proportion with plaque ulceration was 
significant in ischemic stroke patients with a low degree of stenosis (0-49%), whereas a trend toward 
significance was observed in patients with a stenosis of ≥50%. The inverse association observed 
between the calcification proportion and plaque ulceration was significant in patients with a low 
degree stenosis. Furthermore, only a weak correlation was observed between the degree of carotid 
artery stenosis and plaque volume on MDCTA. Importantly, plaque volume was associated with 
plaque ulceration, even after adjustment for the severity of stenosis. Overall, these findings 
demonstrate that the associations between plaque composition and volume with plaque ulcerations 
are present in ischemic stroke patients irrespective of the degree of the carotid plaque stenosis. In 
addition, an etiological explanation is provided for the previously observed correlation of plaque 
characteristics with ischemic stroke events. Herein, a key role is suggested for plaque ulceration in 
the pathophysiological cascade between the development of a heterogeneous plaque and 
thromboembolic stroke. In consequence, apart from degree of stenosis, assessment of carotid 
plaque composition and volume which predispose ulceration could contribute to risk stratification for 
plaque instability or stroke recurrence.  
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Study Limitations  
First, the study has a cross-sectional design. Indeed, the prognostic value of plaque composition 
analysis with MDCTA, and more specifically of the LR-NC proportion for the development of plaque 
ulceration and subsequent thromboembolic ischemic stroke should be confirmed in longitudinal 
serial imaging studies. Second, in the current study the presence of intraplaque hemorrhage was 
not evaluated as plaque composition analysis software used in the current study has not been 
validated for differentiation of intraplaque hemorrhage. As a result, both LR-NC and fibrous tissue 
assessed with MDCTA may contain intraplaque hemorrhage if present in the plaque. Finally, plaque 
composition analysis can be performed on routine MDCTA scans used for carotid stenosis 
evaluation. Nevertheless, every MDCTA leads to ionizing radiation exposure. Therefore, repeated 
examinations should not be advocated. 
 
Clinical and Research Implications 
To our knowledge, the present study is the first to examine the associations between carotid plaque 
characteristics and carotid plaque ulceration in ischemic stroke patients with a ≥50% stenosis, as 
well as in those with a low degree stenosis of 0% to 49%. The LR-NC proportion was identified as 
the strongest determinant for plaque ulceration. The association between the LR-NC proportion and 
carotid plaque ulceration was independent of the degree of stenosis. Plaque composition analysis 
with MDCTA may prove useful for detection of rupture-prone plaques and could potentially improve 
risk stratification in ischemic stroke patients. 
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Background: Atherosclerotic carotid plaque rupture may lead to thromboembolization, causing 
transient ischemic attack or ischemic stroke. Carotid plaque ulceration on angiography is associated 
with plaque rupture. Although healing of ruptured plaques has been described in coronary arteries, 
little is known about the natural development of plaque ulcerations in carotid arteries. We therefore 
explored the evolution of carotid plaque surface morphology with serial multidetector CT angiography 
(MDCTA). 
Methods: From a registry of patients with transient ischemic attack or minor ischemic stroke, we 
selected 83 patients who had undergone serial MDCTA of the carotid arteries. Arteries subjected to 
revascularization procedures between the two scans were excluded (n = 11). Plaque surface 
morphology was classified as smooth, irregular or ulcerated on both baseline and follow-up MDCTA. 
Progression (i.e. development of irregularities or ulceration) and regression (i.e. disappearance of 
irregularities or ulceration) in morphology were evaluated.  
Results: The mean time interval between the MDCTA scans was 21 ± 13 months. At baseline, 28 
(18%) arteries were normal, 124 (80%) contained atherosclerotic plaque and 3 (2%) were occluded. 
Plaque surface morphology was smooth in 86 arteries (55%), irregular in 23 (15%) and ulcerated in 
15 (10%). At follow-up, surface morphology was unchanged in 88% of arteries, had progressed in 
8% and regressed in 4%. Most importantly, plaque morphology remained unchanged in most 
ulcerated plaques (10/15; 67%). One ulcerated plaque had progressed, whereas 4 had regressed. 
New ulcerations had developed in 2 nonulcerated plaques.  
Conclusion: MDCTA allows evaluation of temporal changes in atherosclerotic carotid plaque 
morphology. Plaque surface morphology remained unchanged in most arteries. Carotid ulcerations 
persist for a long time, and may remain a potential source of thromboembolism.  
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Introduction 
Carotid plaque ulceration is associated with plaque rupture, which is an important element in the 
cascade between vulnerable plaque and the occurrence of thrombo-embolic events.1-3 In addition to 
this, carotid plaque ulcerations may be an additional cause of embolic stroke due to local flow 
disturbances.4-6 While there is evidence of a healing process of plaque ruptures in the coronary 
arteries which contributes to the degree of luminal narrowing, little is known about the healing 
process of plaque ruptures in carotid arteries.7,8  
Current knowledge about the evolution of atherosclerotic plaque rupture is mainly based on 
histological analysis of coronary arteries in autopsy studies or carotid plaque specimens obtained 
from carotid endarterectomy.9-13 However, for extensive investigation of the temporal changes of 
plaque surface characteristics and their relation with recurrent thrombo-embolic events, longitudinal 
non-invasive serial imaging studies are required. Computed tomography angiography (CTA) has 
been demonstrated to be superior to angiography in detecting plaque ulcerations and multidetector-
CT angiography (MDCTA) has been found to have a high sensitivity and specificity (94% and 99%, 
respectively) in detecting plaque ulcerations.14,15 Therefore MDCTA is an appropriate non-invasive 
imaging technique for studying plaque ulceration. As MDCTA is able to identify and classify plaque 
ulcerations with a very good interobserver agreement, it is also suitable for serial imaging.16 
To explore the natural history of ulcerated plaques and to assess whether plaque ulcerations heal, 
we studied the temporal changes in plaque surface morphology on serial MDCTA in patients with 
transient ischemic attack (TIA) or minor ischemic stroke.  
 
Materials and Methods 
 
Study population 
From November 2002 till January 2007, 911 consecutive patients with amaurosis fugax, TIA or minor 
ischemic stroke (Rankin score < 4) who underwent MDCTA of the carotid arteries were registered. 
From November 2002 until December 2004, MDCTA was performed as part of a research protocol 
approved by the Institutional Review Board. All patients gave written informed consent. Onwards of 
January 2005, MDCTA was performed as part of standard clinical workup. Patients were enrolled 
from the neurology department’s specialized TIA/stroke outpatient clinic or neurology ward and 
underwent neurological examination on admission; symptoms, risk factors and medication use were 
reported. Follow-up MDCTA scans of the carotid arteries were registered.  
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For the present study we selected the patients from our registry who had undergone more than one 
MDCTA of the carotid arteries in the period November 2002 till December 2008 (n=84). One patient 
was excluded because of poor image quality caused by dental artifacts on both MDCTA scans. If 
more than two MDCTA scans per patient had been performed, the one with the largest lead time 
before any surgical treatment was evaluated in this study. Arteries subjected to revascularization 
procedures between the two scans were excluded (n=11).The present study was approved by the 
Institutional Review Board. 
 
Cardiovascular risk factors 
Hypercholesterolemia was defined as fasting cholesterol > 5.0 mmol/L or treatment with cholesterol-
lowering medication. Hypertension was defined as a systolic blood pressure > 140 mmHg and/or a 
diastolic blood pressure >90 mmHg during two episodes of at least 15 minutes of continuous non-
invasive blood pressure measurement, or treatment with antihypertensive medication. Diabetes was 
defined as serum glucose levels > 7.9 mmol/L, HbA1c > 6.5%, or use of anti-diabetic medication. 
Smoking was categorized as either current smoking or non-smoking. Information was collected on 
previous peripheral vascular disease (intermittent claudication and/or ankle/arm systolic blood 
pressure ratio < 0.85; or a history of related leg amputation, reconstructive surgery or angioplasty), 
previous ischemic TIA or stroke, and previous cardiovascular disease (myocardial infarction, angina 
pectoris, CABG) or otherwise previous cardiac disease (atrium fibrillation, chronic heart failure).  
 
MDCTA data acquisition  
Imaging was performed on a 16-slice multidetector CT scanner (Siemens, Sensation 16, Erlangen, 
Germany) or a 64-slice MDCT scanner (Siemens, Sensation 64) with a standardized, optimized 
contrast-enhanced protocol (120 kVp, 180 mAs, collimation 16 x 0.75 or 32 x 2 x 0.6 mm, pitch 
≤1).17,18 The scan range extended from the ascending aorta to the intracranial circulation. All patients 
received 80 mL of contrast material (Iodixanol 320 mg/ml, Visipaque, Amersham Health, Little 
Chalfont, UK), followed by 40 mL saline bolus chaser, both at an injection rate of 4 mL/sec. Real-
time bolus tracking at the level of the ascending aorta was used to synchronize passage of contrast 
material and data acquisition. Image reconstructions were made with a 120 mm FOV, a matrix size 
of 512 x 512, a slice thickness of 1.0 mm, a slice increment of 0.6 mm, and intermediate 
reconstruction algorithms (B30 and B46). 
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Analysis of the atherosclerotic plaque 
The MDCTA images were sent to a workstation (Leonardo-Siemens Medical Solutions, Forchheim, 
Germany) equipped with dedicated 3-dimensional analysis software. Multi-planar reformatting 
software was used to evaluate both carotid bifurcations in multiple reformations and different planes. 
Each carotid artery was evaluated for the presence of an atherosclerotic plaque, defined as the 
presence of thickening of the vessel wall and/or a calcification in the wall. Atherosclerotic plaque 
surface morphology was evaluated and classified as smooth, irregular or ulcerated. Plaques were 
classified as ulcerated if contrast material extended into the plaque, being visible in at least two 
perpendicular planes. The number of ulcerations per carotid artery was recorded. Irregularities were 
described as prestenotic or poststenotic dilatation and/or irregular plaque-surface morphology 
without extension of contrast material into the plaque. Plaques that were not ulcerated or irregular 
were classified as smooth. The interobserver agreement for the presence of plaque ulceration as 
described above was found to be good (kappa=1.00; 95% CI 0.86-1.00).16 
In addition, plaque density was evaluated as previously described by Saba et al.19 In atherosclerotic 
carotid plaques, the mean Hounsfield unit attenuation was measured within manually drawn regions 
of interest covering the plaque on three consecutive axial images at the level of largest plaque 
burden. Plaque density was classified as soft, mixed or calcified, according to cut-off values derived 
from a method validated by Schroeder et al: soft plaques with mean density values < 50 HU, 
intermediate plaques with mean density values between 50 and 119 HU and calcified plaques with 
a mean density value ≥ 120 HU.20  
The number of calcifications in the investigated plaques was manually counted within a range of 3 
cm above to 3 cm under the bifurcation point. An automated calcium scoring tool was used to assess 
calcium volumes within this same range, using a cut-off value of 600 HU to differentiate calcifications 
from contrast material in the lumen.  
 
Assessment of changes in plaque morphology 
The atherosclerotic plaque morphology at baseline and follow-up MDCTA were evaluated 
separately, with a time interval of more than one month between the two assessments. Two 
experienced observers blinded to clinical data analyzed the MPR images. Discrepancies were 
resolved by consensus. Additionally, temporal changes in morphology between baseline and follow-
up MDCTA scans were verified by a consensus reading where necessary. Changes in 
atherosclerotic plaque morphology were considered as progression if irregularities, ulceration or 
occlusion had developed. Regression was defined as disappearance of ulceration or irregularities.  
 




Where appropriate, data are presented descriptively as numbers and percentages and means  
standard deviations (SD). We evaluated the association between cardiovascular risk factors and 
baseline plaque morphology and between cardiovascular risk factors and temporal change in plaque 
morphology. Differences between categorical data and continuous data were analyzed with a χ2 test 
and a Mann-Whitney test or a Student t test, respectively. Temporal changes in continuous data on 
plaque characteristics were analyzed with a paired-samples t test. 
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Results 
In total 83 patients who had undergone a baseline MDCTA as well as a follow-up MDCTA evaluation 
of the carotid arteries were included. The mean time period between the serial scans was 21 ± 13 
months. The mean age in the study population was 60 ± 12 years, and the majority of patients were 
male (64%, Table 1). In 75 patients (90%), the indication for follow up MDCTA was recurrent TIA or 
ischemic stroke; in 39 (47%), the recurrent event was attributed to the same vascular distribution as 
the previous attack, and in 36 (43%) a different vascular territory was involved. In eight patients 
(10%) a follow-up MDCTA was performed for pre- and post-interventional indications or for 
neurological symptoms that could not be attributed to a specific vascular territory.  
 
Table 1. Baseline characteristics of the study population 
 Total Patients (N=83) 
Age (years, mean ± SD)                                  
Gender (% male)                                             
Risk factors (%): 
- previous cerebrovascular disease   
- previous cardiovascular disease  
- peripheral vascular disease  
- hypertension                                          
- hypercholesterolemia                                   
- diabetes mellitus                                          
- smoking                                            
Cerebrovascular symptoms (%): 
    Amaurosis fugax 
    TIA 
    Minor stroke 
Symptomatic artery (%): 
    Carotid 
    Vertebrobasilar 

















Data are means±SD or number of patients (%).  
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Of the 166 carotid arteries in 83 patients, 11 arteries were excluded, because of treatment by carotid 
endarterectomy (n=3) or because of stent placement (n=8) in the period between the baseline and 
follow-up MDCTA. One-hundred-fifty-five carotid arteries were available for analysis of changes in 
atherosclerotic plaque characteristics on follow-up MDCTA. 
 
Table 2. Plaque characteristics of 155 carotid arteries on baseline and on follow-up MDCTA 




   Plaque surface morphology 
   Smooth plaque surface 
   Irregular plaque surface 
   Ulcerated plaque 
       Number of ulcerations 
       1 
       2 
       3 
   Plaque density * 
       Soft plaque 
       Mixed plaque 
       Calcified plaque 
   Calcifications ** 
       Mean number of calcifications  

















4.9  3.5 

















4.6  3.2 
62.8  92.2 
* Assessed in carotid arteries containing plaque ** Assessed in carotid arteries containing plaques 
with calcification at baseline (n=102) 
Table 2 shows plaque characteristics of the carotid arteries on baseline and follow-up MDCTA scans.  
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At baseline, 28 (18%) carotid arteries were normal, 124 (80%) contained atherosclerotic plaque, and 
3 arteries were occluded. The majority (n=86, 55%) of vessels had a smooth plaque surface, 
whereas 23 (15%) had irregular plaque surfaces. Fifteen of the 155 vessels (10%) had an ulcerated 
plaque surface; most arteries contained one ulceration. These ulcerated plaques were present in 15 
patients. Most of the plaques (119/124; 96%) were mixed or calcified plaques, since the majority of 
carotid plaques (102/124, 82%) contained at least some calcifications. The mean HU density of the 
124 plaques at baseline was 179  147 HU, which increased to 216  187 HU over time (p=0,001). 
The number of calcifications did not significantly change over time (4.9 ± 3.5 at baseline versus 4.6 
± 3.2 at follow-up, p=0.21), whereas calcium volume increased significantly (44.7  72.1 mm3 at 
baseline versus 62.8  92.2 mm3 at follow-up, p<0.001)  
 



























































Data are number (%).  
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Changes in surface morphology between the baseline and the follow-up MDCTA are presented in 
Table 3. On the follow-up MDCTA the surface morphology was unchanged in 137 (88%) of the 
carotid arteries, whereas 12 (8%) had progressed and 6 (4%) had regressed. The 12 arteries that 
had progressed were present in 10 patients. The morphology of most ulcerated plaques (10 out of 
15) had not changed over a mean time period of 20 ± 15 months, as illustrated by an example in 
figure 1.  
 
 
Figure 1. Multiplanar reformat images (on top) and axial images (below) showing a carotid bifurcation 
of the same patient with plaque ulceration (arrows) in the proximal internal carotid artery. The time 
delay between the MDCTA scans was 11 months (A  B) and 13 months (B  C) respectively. No 
change in appearance of plaque morphology is found. 
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A second ulceration evolved in one ulcerated plaque (over 21 months), whereas a new ulceration 
developed in two non-ulcerated plaques (over 29 and 40 months). Four ulcerated plaques regressed 
(over 3, 9, 14 and 44 months), of which an example is shown in figure 2.  
 
Figure 2. Multiplanar reformat images (on top) and axial images (below) of a carotid bifurcation with 
a time delay between the MDCTA scans of 9 months. The plaque ulceration (arrows) disappeared 
over time, leaving a smooth plaque surface. 
We did not find any associations between cardiovascular risk factors and baseline plaque 
morphology and between cardiovascular risk factors and temporal change in plaque morphology. 
There was no relation between changes in plaque morphology and the occurrence of TIA or ischemic 
stroke at baseline or follow-up (Table 4). 
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Table 4. Relation between changes in plaque morphology and symptomatology of the carotid 
arteries. Shown are the number of carotid arteries presenting with a particular plaque morphology 
on baseline and on follow-up MDCTA and the number of these arteries that became symptomatic or 
asymptomatic (AS = asymptomatic, S = symptomatic). 
Baseline Follow-up  N AS  S AS  AS S  AS S  S 
no plaque no plaque 24 4 11 4 5 
smooth smooth 81 14 37 15 15 
irregular irregular 19 5 7 2 5 
1 ulceration 1 ulceration 8 1 4 3 0 
2 ulcerations 2 ulcerations 1 0 1 0 0 
3 ulcerations 3 ulcerations 1 1 0 0 0 
occlusion occlusion 3 0 1 0 2 
 Total unchanged 137 25 61 24 27 
no plaque smooth 4 1 2 1 0 
smooth irregular 4 1 0 3 0 
smooth 1 ulceration 1 1 0 0 0 
irregular occlusion 1 0 0 0 1 
irregular 1 ulceration 1 1 0 0 0 
1 ulceration 2 ulcerations 1 0 1 0 0 
  Total progression 12 4 3 4 1 
1 ulceration irregular 3 2 1 0 0 
2 ulcerations 1 ulceration 1 1 0 0 0 
irregular smooth 2 0 1 0 1 
  Total regression 6 3 2 0 1 
  Total 155 32 66 28 29 
Data are number.  
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Discussion 
This is the first MDCTA study that longitudinally evaluates the natural evolution of carotid plaque 
surface morphology. Our results show that plaque surface morphology remains largely unchanged 
and that regression and progression occur in just a minority of plaques after a time period of 21 ± 13 
months. Most importantly, plaque ulcerations do not disappear; 10 out of 15 ulcerated plaques had 
a similar appearance after 20 ± 15 months. Mean plaque density increased over time, while the 
number of calcifications did not change significantly. The increased density can be explained by the 
increase in volume and density of the calcifications.  
Carotid plaque ulceration is associated with fibrous cap rupture, which is an important cause of 
thrombo-embolic events.1,3,12 Current imaging modalities allow the visualization of carotid plaque 
ulceration, which is associated with cap rupture and other features of plaque instability.1 The site of 
ulceration probably represents part of the plaque where fibrous cap and part of the necrotic core has 
disappeared and has most probably embolized.13 However, our results show that plaque ulceration 
on MDCTA images does not necessarily suggest that the plaque rupture is recent.  
Since a healing process of ruptured coronary plaques has been described in histological studies, 
our finding of temporarily unchanged carotid plaque ulcerations on serial MDCTA imaging was 
unexpected.7,8 In coronary arteries a mechanism of plaque healing has been reported in which layers 
of collagen, proteoglycan-rich matrix and smooth muscle cells overly the ruptured cap and contribute 
to increased luminal narrowing.7,8,13 One case report has described the concept of rupture and 
healing in a carotid atherosclerotic plaque visualized with magnetic resonance imaging (MRI).21 We 
therefore expected that carotid plaque ulcerations might fill and disappear. Our findings may be 
explained by the differences in vessel size and hemodynamic forces in carotid arteries compared to 
coronary arteries, or by the possibility that ulcerations reflect the more severely ruptured plaques. It 
is uncertain which time interval should be regarded as sufficient to demonstrate long term changes 
in plaque morphology. However, we consider a mean follow-up period of almost two years sufficient 
to evaluate changes, since healing of ulceration as assessed with MRI has been reported to occur 
within two months.21  
Our results are indirectly supported by some observations that also question the concept of healing 
of carotid plaque ulcerations. Whereas a histological study found plaque ulcerations to be more 
common in symptomatic carotid arteries than in asymptomatic arteries (36% versus 14%, p<0.0001), 
the prevalence of ulceration in the ipsilateral and contralateral carotid artery in symptomatic patients 
was the same.22 Likewise, an MDCTA study reported that the prevalence of complicated plaques 
(i.e. irregularities and ulcerations) was 25% in symptomatic carotid arteries and 18% in asymptomatic 
carotid arteries.16  
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Whereas ulcerations seem to correlate with symptomatic arteries, they are also present in 
asymptomatic arteries. This might be explained either by the fact that not every plaque rupture leads 
to thrombosis and embolization, or that the embolized particles dissolve or cause clinically silent 
infarctions. Another explanation of the incidental detection of ulcerations in asymptomatic arteries 
may be that plaque ulcerations heal very slowly or do not disappear at all. The findings correspond 
with our own: ulcerations can persist unchanged for a long time in both symptomatic and 
asymptomatic carotid arteries.  
Persisting plaque ulceration may be a potential imaging-based stroke-risk predictor. The presence 
of plaque ulceration on angiography has been found to be associated with recurrent stroke in patients 
with a previous ischemic cerebral event.23 The question is whether persisting ulcer cavities should 
be regarded merely as a scar after a previous plaque rupture or also as a potential source of 
thromboembolization. Indeed, some local factors at the level of ulceration have been found to play 
an important role in the development of new thrombi. Firstly, plaque ulcerations may induce 
thrombus formation by disturbing the blood flow. In-vitro flow experiments with ultrasound showed 
that the flow downstream from ulcerated, moderate stenotic, carotid plaques was more disturbed 
than from non-ulcerated plaques.21 Similarly, an experimental slipstream visualization technique 
showed that the introduction of an ulceration into a stenotic carotid bifurcation produced observable 
flow disturbances.4 Further, color flow Doppler ultrasound, which uses detection of vortices, is useful 
in detecting ulcerated plaques.25 Moreover, local flow disturbance caused by ulcerations is likely to 
favor thrombo-genesis.5,6 Secondly, plaque ulcerations may induce thrombus formation by 
possessing an erosive surface. Whereas histological studies describe plaque healing as the 
deposition of a collagen matrix superimposing the ruptured cap they have not described re-
endothelialization. Future studies should examine whether the surfaces of persistent ulcerations are 
pro-thrombotic.7 
The clinical and pathophysiological importance of the distinction between ulcerations and 
irregularities is unknown. There is no evidence that ulcerated plaques on angiographic criteria are 
any more likely to lead to thrombus formation than irregular plaques. Rothwell et al. found that 
plaque-surface irregularities were highly predictive of ipsilateral ischemic stroke and significantly 
associated with macroscopic surface ulceration and thrombus formation.26 Our results show that 19 
out of 23 irregular plaques on the baseline MDCTA remained unchanged on follow-up MDCTA. Our 
considerations with regard to the consequences of persisting ulcerations might also apply to plaque 
irregularities. 
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The strength of this serial imaging study is that it presents a way to non-invasively study the 
development of atherosclerotic plaques in human beings. Serial MDCTA provides additional 
information that is otherwise difficult to achieve by enabling the investigation of the atherosclerotic 
plaque in earlier stages, at various time points in the same patient, and in patients in whom no 
histological material is available. MRI is potentially suitable for serially studying carotid plaque 
rupture in more detail. Although the status of the fibrous cap has been studied with MDCTA, no 
validation with histology is available.27 MRI can distinguish intact, thick fibrous caps from intact thin 
and disrupted caps in human atherosclerotic carotid arteries in vivo.28 By using MRI, Underhill et al. 
evaluated the predictive value of plaque characteristics for new plaque surface disruption.29 Thin or 
ruptured fibrous caps have been associated with subsequent symptoms during follow-up.30  
Our study has some limitations. First, the relatively small study population and the low overall 
prevalence of ulcerations meant that we found a small number of ulcerations. Nevertheless, we 
found a clear trend of mainly unchanged ulcerated plaque morphology. The second limitation was 
the study design and our selection of patients with follow-up scans that were performed for clinical 
reasons. These provided a relatively small and heterogeneous study population that was unsuitable 
for evaluating the correlation between changes in plaque morphology and symptomatology. 
Temporal changes in plaque ulceration should thus be correlated with recurrent thrombo-embolic 
events by including a larger number of patients in a prospective, long term follow-up study. The small 
selected study population may also underlie the absence of an association between classical 
cardiovascular risk factors and plaque morphology. Further, these limitations impeded the structural 
co-evaluation of other important plaque characteristics. The third limitation is that we evaluated 
temporal changes at the level of the carotid artery. Since atherosclerosis is a systemic disease and 
atherosclerotic plaques are thought to be liable to systemic influences, we might have expected 
progression or regression of plaque morphology to be clustered in particular patients. However, we 
did not find such clustering.  
 
Summary 
In conclusion, by demonstrating that ulcer cavities usually persist for a long time, the results of this 
serial MDCTA study contribute to the knowledge of the evolution of ulcerated plaques. Our findings 
suggest that the detection of plaque ulceration on MDCTA images may not have a direct diagnostic 
value as it may not represent a recent plaque rupture. However, persisting carotid ulcerations may 
remain a potential source of embolism. Further studies should reveal whether persisting plaque 
ulcerations constitute an important source of recurrent thrombo-embolism and whether they may aid 
future stroke-risk prediction and clinical decision-making in individual patients. 
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Background and Purpose: Intracranial arterial stenosis (IAS) in patients with recent ischemic 
stroke is associated with a high risk of recurrent stroke. More insight into the pathophysiology of IAS 
could help identify high risk patients requiring more aggressive secondary prevention. We evaluated 
the prevalence, distribution, calcification and the risk factors predisposing IAS in a European stroke 
population. 
Methods: Consecutive patients with a transient ischemic attack or ischemic stroke (n=786) were 
evaluated for the presence and distribution of IAS (≥30% luminal narrowing) by CT angiography. IAS 
were categorized as symptomatic or asymptomatic, and the presence of calcification was assessed. 
The association of traditional cerebrovascular risk factors and the erythrocyte sedimentation rate 
(ESR) with IAS was analyzed. 
Results: In 178/786 patients (23%), 288 IAS were observed. Most stenoses (n=194/288, 67%) were 
located in the posterior circulation arteries. In 59/786 patients (8%) IAS were considered 
symptomatic. IAS in the basilar artery and arteries beyond the circle of Willis were mainly non-
calcified. In addition to age, gender and several traditional cerebrovascular risk factors, ESR was 
independently associated with the presence of IAS (OR 1.20; 95%CI 1.06-1.36), and with the 
presence of non-calcified IAS in particular (OR 1.20; 95%CI 1.05-1.37).  
Conclusions: IAS was observed in a noteworthy number of European stroke patients. Particularly, 
the majority of IAS was observed in the posterior circulation, possibly conferring worse prognosis. 
IAS in distal arteries were mainly non-calcified. Association of non-calcified IAS and ESR may 
indicate a prominent role for inflammatory factors in intracranial atherosclerotic disease. 
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Introduction 
Intracranial arterial stenosis (IAS) in patients with transient ischemic attack (TIA) or ischemic stroke 
is associated with a high risk of recurrent stroke.1 Angioplasty and stenting are feasible procedures 
for revascularization of vessels affected by IAS. However, insufficient evidence is available to 
recommend these treatments for the prevention of recurrent stroke in patients with IAS in clinical 
practice.2 More insight into the prevalence, distribution and calcification of IAS lesions could help 
identify high risk patients requiring more aggressive secondary prevention. 
The prevalence of IAS seems to vary among ethnic groups.3 Nevertheless, only limited studies have 
assessed the prevalence and associated risk factors for IAS in European stroke patients.4-6 
Moreover, the comparative value of studies available in European patients is limited by the use of 
multiple imaging modalities.  
Also, little is known about the composition of IAS lesions, which may point to a specific 
pathophysiological process.7 The pathophysiology of intracranial atherosclerosis is suggested to 
differ from that of the extracranial arteries.8 A prominent role for inflammatory factors is indicated in 
the atherosclerosis of the intracranial arteries.9 Consequently, the pro-atherogenic influence of 
inflammatory reactions could be manifested as an association between the erythrocyte 
sedimentation rate (ESR) and IAS, as previously observed in a single study.10 In addition, an 
accelerated intracranial atherogenesis could be reflected in differences in plaque calcification. 
Multidetector computed tomography angiography (MDCTA) is reliable for the evaluation of both 
extracranial11 as well as intracranial atherosclerotic disease.12 Moreover, the technique is available 
for detection of IAS in most European hospitals.13 As compared to digital subtraction angiography 
(DSA), MDCTA has been demonstrated to be effective in the detection of IAS with a sensitivity of 
97% and a specificity of 99%.12 In addition, MDCTA allows differentiation between calcified and non-
calcified atherosclerotic plaques.14  
In the current study we evaluated a large cohort of patients with TIA or ischemic stroke for the 
prevalence, distribution and the calcification of IAS lesions using MDCTA. Furthermore, the 
association of IAS with the traditional risk factors for cerebrovascular disease as well as with ESR 
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Materials and Methods 
 
Study Population 
From a prospective registry of 911 consenting patients with amaurosis fugax, TIA or ischemic stroke 
(Rankin <4 at discharge) we selected all patients (n=795) with a recent ischemic stroke or TIA, but 
excluded patients with amaurosis fugax. Patients were enrolled from a specialized TIA/stroke 
outpatient clinic or the stroke unit. All patients were interviewed and examined by a vascular 
neurologist, and underwent electrocardiography and laboratory analysis. Medical history and 
cerebrovascular risk factors were recorded. On admission, patients underwent MDCT of the brain 
and MDCTA of the carotid and intracranial arteries in a single session. Three patients with an 
MDCTA of insufficient quality for reliable evaluation, and 6 patients with intracranial arteries outside 
the scan reconstruction area were excluded. Consequently, analyses were performed in the 
remaining 786 patients.  
 
Risk Factors  
Ethnicity of patients was determined through an algorithm, based on place of birth of the patients 
and their parents, as well as on name and surname.15 For the purpose of this study, we distinguished 
between Asian and non-Asian ethnicities. History of ischemic heart disease was defined as previous 
chronic heart failure, angina pectoris, myocardial infarction or coronary artery bypass grafting. 
Hypercholesterolemia was defined as fasting cholesterol >5.0 mmol/L or treatment with cholesterol-
lowering medication. Hypertension was defined as a systolic blood pressure >140 mmHg and/or a 
diastolic blood pressure >90 mmHg, during two episodes of at least 15 minutes of continuous 
noninvasive blood pressure measurement or treatment with antihypertensive medication. Diabetes 
was defined as fasting serum a glucose level >7.9 mmol/L, HbA1c >6.5%, or use of antidiabetic 
medication. Laboratory analysis included total cholesterol, HDL cholesterol, LDL cholesterol, 
triglycerides and glucose, as well as ESR. 
 
MDCT and MDCTA Data Acquisition and Analysis 
MDCTA was performed with a 16-slice MDCT scanner (Siemens, Sensation 16, Erlangen, Germany) 
or a 64-slice MDCT scanner (Siemens, Sensation 64, Erlangen, Germany) with a standardized 
protocol.16,17  
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Intracranial arteries were evaluated on a stand-alone workstation (Leonardo – Siemens Medical 
Solutions, Forchheim, Germany) with multiplanar reformatting and maximum intensity projection 
images of 4 mm thickness (Figure 1). Since symptomatic ulceration with superimposed thrombus of 
intracranial atherosclerotic plaques is also present in low grade stenosis, we defined IAS as ≥30% 
luminal narrowing.18 The degree of stenosis was measured according to the WASID criteria on 
oblique multiplanar reformatting images perpendicular to the central lumen line.19 Stenoses were 
classified as 30-49%, 50-69% and 70-99%. The internal carotid arteries (ICA), the anterior cerebral 
arteries (ACA), the medial cerebral arteries (MCA), the vertebral arteries (VA), the basilar artery 
(BA), and the posterior cerebral arteries (PCA) were analyzed. 
 
Figure 1. Assessment of IAS using MDCTA. Upper row: maximum intensity projection images of 4 
mm thickness demonstrating an IAS of 30-49% in the right posterior cerebral artery (A), an IAS of 
50-69% in the left anterior cerebral artery (B), and an IAS of 70-99% in the basilar artery (C). Lower 
row: volume rendering images demonstrating the same IAS lesions in 3D anatomy.  
 
Blinded to clinical information, two trained observers (PJH and GJJP) independently analyzed the 
presence of IAS according the WASID method in the first 50 patients. After 4 weeks, the first observer 
analyzed the same 50 patients. Good interobserver agreement (κ=0.79; 95%CI 0.55-1.02) and 
intraobserver agreement (κ=0.79; 95%CI 0.60-0.99) was observed.  
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A calcified IAS lesion was defined as any intracranial stenosis (≥30%) containing plaque 
calcifications (>130 Hounsfield units). Symptomatic IAS was defined as any intracranial stenosis 
(≥30%) in an artery supplying the involved region of the brain, taking into account the configuration 
of the circle of Willis. 
 
Statistical Analysis 
Differences between variables were tested with the chi-square test, Fisher's exact test, Mann-
Whitney test or a non-parametric rank test where appropriate. The association of traditional 
cerebrovascular risk factors and ESR with the presence of IAS was determined using regression 
analysis. The risk factors significantly associated with IAS (P<0.05) in the univariable regression 
analysis, which were not directly interrelated, were included in a multivariable regression model. 
Associations were expressed as odds ratio (OR) with 95% confidence interval (CI). The analysis was 
repeated for the presence of non-calcified IAS lesions, calcified IAS lesions and symptomatic IAS in 
patients. For the purpose of this analysis patients with solely non-calcified IAS lesions were 
considered as ‘patients with non-calcified IAS lesions’ whereas patients with any calcified IAS lesions 
were considered as ‘patients with calcified IAS lesions’. Statistical analyses were performed using 





Prevalence, Distribution and Calcification of IAS  
Most patients were male (n=513; 56%) and the mean age was 62±14 years. Baseline characteristics 
of patients with and without IAS are illustrated in Table 1. The presence and severity of IAS in 
different arteries are shown in Table 2. IAS of ≥30% was observed in 178 patients (23%). IAS of 
≥50% was present in 77 patients (10%), and IAS of ≥70% in 21 patients (3%). In total 288 IAS (≥30%) 
were observed.  
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Table 1. Baseline characteristics of the study population.  
 No IAS  
(n=608; 77%) 
IAS  
(n=178; 23%) P-value 
Age 60±14 68±12 <0.001 
Male sex 332 (55%)  110 (62%)  0.09 
Asian ethnicity 20 (3%)  16 (9%)  0.001 
Index event     
TIA  238 (39%)  47 (26%) 0.002 
Ischemic stroke 370 (61%)  131 (74%)  
Time since onset (days) 5 (1-14) 5 (0-18) 0.40 
Cerebrovascular history    
Previous ischemic stroke 77 (13%)  32 (18%)  0.07 
Previous TIA> 6 months 85 (14%)  30 (17%)  0.34 
History of ischemic heart disease 101 (17%)  33 (19%)  0.55 
Cerebrovascular risk factors    
Hypercholesterolemia 440 (72%)  135 (76%)  0.36 
Hypertension 389 (64%)  146 (82%)  <0.001 
Diabetes mellitus 92 (15%)  53 (30%)  <0.001 
Atrial fibrillation 39 (6%)  14 (8%)  0.50 
Smoking  230 (38%)  56 (31%)  0.12 
Laboratory results    
Cholesterol (mmol/l) 5.2±1.1 5.3±1.2 0.38 
HDL cholesterol (mmol/l) 1.41±0.51 1.40±0.74 0.51 
LDL cholesterol (mmol/l) 3.29±1.04 3.47±1.19 0.15 
Triglycerides (mmol/l) 1.72±2.54 1.71±0.96 0.16 
Glucose (mmol/l) 4.9±1.7 5.7±2.4 <0.001 
ESR (mm/hr) 13±12 16±15 0.001 
Extracranial carotid artery 
stenosis ≥50% 
50 (8%)  38 (21%)  <0.001 
Data are means±SD, median (interquartile range) or number of patients (%).  
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In 184/288 IAS (64%) the degree of stenosis ranged 30-49%, in 83/288 IAS (29%) 50-69%, and in 
the remaining 21/288 IAS (7%) 70-99%. Occlusions were present in 52 arteries. Interestingly, the 
majority of IAS (n=194/288; 67%) was located in the posterior circulation. Stenoses of ≥70% 
occurred mainly in the posterior circulation of the brain. Exclusively non-calcified IAS lesions were 
observed in 126 patients (16%). In total 221/288 IAS lesions (77%) were non-calcified. IAS lesions 
in the ACA, MCA and BA were exclusively non-calcified. Calcified IAS lesions were predominantly 
present in the proximal arteries (ICA and VA; n=64), whereas only 3 calcified IAS lesions were 
identified in the PCA. In 59 patients (8%) a total of 63 symptomatic IAS ≥30% was observed. 
Symptomatic IAS of ≥50% was present in 18 of the patients (3%). Overall, symptomatic IAS 
comprised of 39 stenoses in the anterior circulation and 24 stenoses in the posterior circulation. 
 
Table 2. Distribution and severity of IAS (n=288) 
 
Data are number of IAS (% of all IAS). 
 
Risk Factors associated with IAS 
Multivariable analysis revealed an independent association between IAS and age, male sex, Asian 
ethnicity, hypertension, diabetes mellitus, LDL cholesterol and ESR (Table 3). Risk factors 
independently associated with non-calcified IAS lesions and calcified IAS lesions are provided in 
Table 4. Age, male sex, hypertension, diabetes mellitus, LDL cholesterol and ESR remained 
independently associated with non-calcified IAS lesions, whereas only age was independently 
associated with calcified IAS lesions. The median time since symptom onset and clinical and 
laboratory analysis was 5 days (1-14).  
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Table 3. Uni- and multivariable analysis of risk factors associated with IAS.  
 OR (95% CI) OR (95% CI) 
Age (per 10 years)* 1.65 (1.43-1.90) 1.65 (1.40-1.94) 
Male sex  1.34 (0.96-1.89) 1.55 (1.05-2.29) 
Asian ethnicity 2.90 (1.47-5.73) 2.68 (1.20-5.98) 
Index event   
Ischemic stroke 1.79 (1.24-2.60) - 
Cerebrovascular history   
Previous ischemic stroke 1.51 (0.96-2.37) - 
Previous TIA> 6months 1.25 (0.79-1.96) - 
History of ischemic Heart Disease  1.14 (0.74-1.76) - 
Cerebrovascular risk factors   
Hypercholesterolemia 1.20 (0.81-1.76) - 
Hypertension 2.57 (1.69-3.90) 1.87 (1.16-3.00) 
Diabetes mellitus 2.38 (1.61-3.51) 2.08 (1.34-3.22) 
Atrial fibrillation 1.25 (0.66-2.35) - 
Smoking  0.75 (0.53-1.08) - 
Laboratory results   
Cholesterol (mmol/l)* 1.13 (0.97-1.30) - 
HDL cholesterol (mmol/l)* 0.99 (0.74-1.34) - 
LDL cholesterol (mmol/l)* 1.17 (0.99-1.36) 1.33 (1.12-1.59) 
Triglycerides (mmol/l)* 1.00 (0.93-1.08) - 
Glucose (mmol/l)* 1.19 (1.10-1.29) - 
ESR (per 10mm/h)* 1.22 (1.09-1.37) 1.20 (1.06-1.36) 
Extracranial carotid artery stenosis ≥50% 3.03 (1.91-4.80) - 
*Ratio-per-unit increase. CI = confidence interval; OR = odds ratio. 
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Table 4. Multivariable analysis of risk factors associated with exclusively non-calcified IAS lesions, 
calcified IAS lesions and symptomatic IAS.  
 
OR (95% CI)  
Non-calcified IAS 
lesions (n=126; 16%) 
OR (95% CI) 
Calcified IAS 
lesions (n=52; 7%) 
OR (95% CI)  
Symptomatic IAS 
(n=59; 8%) 
Age (per 10 years)* 1.37 (1.15-1.63) 2.09 (1.56-2.82) 1.37 (1.07-1.75) 
Male sex 1.56 (1.01-2.40) 1.29 (0.68-2.45) 1.60 (0.87-2.92) 
Asian ethnicity 2.02 (0.88-4.62) 2.52 (0.76-8.36) 3.69 (1.49-9.14) 
Hypertension 1.74 (1.02-2.96) 1.84 (0.79-4.31) 3.04 (1.23-7.49) 
Diabetes mellitus 2.13 (1.32-3.42) 1.37 (0.67-2.81) 1.52 (0.80-2.86) 
LDL cholesterol (mmol/l)* 1.29 (1.07-1.57) 1.25 (0.94-1.67) 1.08 (0.83-1.41) 
ESR (per 10mm/h)* 1.20 (1.05-1.37) 1.09 (0.88-1.35) 1.23 (1.04-1.46) 
*Ratio-per-unit increase. CI = confidence interval; OR = odds ratio. 
 
The association of ESR with IAS remained present after adjustment for time between onset of 
symptoms (OR 1.22; 95%CI 1.08-1.36). Interestingly, ESR increased with degree of intracranial 
stenosis (Figure 2). Age, Asian ethnicity, hypertension and ESR were independently associated with 
symptomatic IAS.  
Figure 2. Boxplot illustrating higher 
median ESR rates with increase of 
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Discussion  
In the current study, IAS of ≥30% was observed in 178 patients (23%) with a recent ischemic stroke 
or TIA. The majority of all IAS was located in the posterior circulation arteries. Symptomatic IAS of 
≥30% was observed in 59 patients (8%). Calcified IAS lesions were predominantly observed in the 
proximal intracranial arteries (ICA and VA), whereas IAS lesions in the distal intracranial arteries 
(BA, ACA, MCA and PCA) were mainly non-calcified. A number of traditional risk factors including 
age, male sex, Asian ethnicity, hypertension, diabetes mellitus, and LDL cholesterol were 
independently associated with the presence of IAS in multivariable analysis. An independent 
association was also observed between ESR and IAS. Equivalent traditional risk factors and ESR 
were also associated with non-calcified IAS lesions. However, age was the only risk factor 
associated with calcified IAS lesions. 
 
Prevalence and Distribution of IAS  
The comparability of studies on the prevalence of IAS in stroke patients is limited due to the variation 
in the studied populations, definition of IAS, and used imaging modalities. Thus far, large studies on 
the prevalence, distribution and risk factors predisposing IAS have been mainly performed in Asian 
stroke populations.20-22 Relatively high prevalences of 26 to 54% were observed in studies of different 
Asian populations of stroke patients. In contrast, limited studies have evaluated the prevalence of 
IAS in Europe.4-6 In a multicenter European study by Weimar et al., using various imaging modalities, 
symptomatic IAS of ≥50% was observed in 6.5% of the evaluated stroke patients.6 In contrast, the 
results of the present study reveal a lower prevalence of symptomatic IAS of ≥50% in European 
stroke patients (3%). The difference in prevalence can be in part explained by the inclusion of a 
higher proportion of patients with a TIA and the exclusion of patients with severe ischemic stroke 
(Rankin <4 at discharge) in the current study.  
Observed prevalence and distribution of IAS are also influenced by the applied imaging modality.23 
In general, transcranial doppler (TCD) is more operator dependent and obtained results vary 
according to operator skills. Moreover, TCD is suggested to be less sensitive than CT angiography 
for the detection of IAS in the posterior circulation.23,24 However, in Asian patients with TIA and 
ischemic stroke, the anterior circulation seems to be the predilection site in the distribution of IAS 
irrespective of the imaging modality.25-27 Distribution of IAS reported in European stroke patients has 
been less consistent. Using either DSA or ultrasonography for primary detection, Mazighi et al. 
reported a similar distribution of IAS in the anterior and posterior circulation.4 In contrast, using 
Doppler/duplex ultrasonography in 99% of the studied patients, Weimar et al. observed a higher 
prevalence of IAS in the anterior (77%) versus the posterior (23%) circulation.6  
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Using MDCTA in current study, the majority of IAS (67%) was located in the posterior circulation. 
Indeed, the lower proportion of IAS in the posterior circulation in the previous European studies may 
be attributable to a detection bias, as investigators have mainly relied on ultrasonography. Of note, 
detection of IAS in the posterior circulation may be an important prognostic determinant as these 
lesions have been associated with a high risk of recurrent stroke.1,28,29  
 
Composition of Intracranial Atherosclerotic Stenotic Lesions 
Thus far, limited imaging studies have evaluated the composition of IAS lesions. CT brain studies 
have reported a predominant presence of calcification in the proximal arteries, but did not combine 
the evaluation of IAS and plaque calcification with MDCTA.30,31 Our findings confirm the presence of 
calcified IAS lesions in the proximal intracranial arteries. However, a majority of non-calcified IAS 
lesions was demonstrated in the distal arteries, which would be neglected on CT brain. This 
implicates that absence of calcification on CT brain does not exclude the presence of IAS in the 
distal arteries. In line with the results of the current study, a previous postmortem histological analysis 
of atherosclerotic plaque composition in the MCA has demonstrated calcification in only a minority 
of the specimens, 31 of 111 (28%).32 
The low prevalence of calcified IAS lesions on MDCTA in the distal intracranial arteries suggests a 
different pathophysiology of atherosclerotic disease in the proximal and distal intracranial arteries. 
The intracranial arteries show significantly greater antioxidant enzyme activities than the extracranial 
arteries.8 Indeed, the greater activity of antioxidant enzymes in intracranial arteries may contribute 
to a greater resistance to atherogenesis. This antiatherogenic activity decreases significantly in older 
age, coinciding with accelerated atherogenesis.8 Consequently, with age, intracranial arteries may 
respond with accelerated atherogenesis as their antioxidant protection decreases more significantly 
than that of the extracranial arteries. In the current study, the higher prevalence of extracranial 
stenosis in patients with IAS supports the loss of protective antioxidant capacity in the extracranial 
arteries at a younger age. In line with this observation, higher plasma C-reactive protein-levels have 
been previously noted in patients with extracranial stenosis as compared to those with isolated MCA 
stenosis.33 
Furthermore, with age, plasma LDL becomes more susceptible to oxidation.34 The oxidative 
modification of LDL may therefore play a key role in this atherogenic process through inflammatory 
reactions.35,36 The presence of mainly non-calcified IAS lesions in the basilar artery and arteries 
beyond the circle of Willis in the current study might be a reflection of this accelerated atherogenesis.  
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Risk Factors Associated with IAS  
A number of traditional risk factors for atherosclerotic disease have been previously related with 
IAS.3,9,37 In addition, high-sensitivity C-reactive protein, a marker of inflammation is associated with 
recurrent ischemic events in the territory of the stenotic artery in stroke patients with IAS.5 Also, ESR 
was shown to be independently associated of with the presence of IAS in a South Asian stroke 
population.10 In the presents study of European patients, IAS lesions were not only associated with 
the traditional risk factors including hypertension, diabetes and LDL cholesterol, but also with ESR. 
Importantly, the association of ESR with IAS remained significant even after adjustment for the time 
since onset of symptoms. Thereby, the contribution of the acute phase reaction as a cause of ESR 
elevation was made less probable. As a result, an independent association was identified between 
ESR and LDL cholesterol with the presence of IAS, and more importantly with the presence of non-
calcified IAS lesions in patients with a recent TIA or ischemic stroke. These findings may indicate a 
prominent role for inflammation in intracranial atherogenesis.35,36 
 
Study Limitations  
The design of the present study is cross-sectional. Indeed, the prognostic value of the presence, 
distribution and calcification of IAS lesions in patients with ischemic stroke or TIA remains to be 
determined in follow-up studies. The pathophysiological mechanisms initiating intracranial 
atherosclerosis were not evaluated. However, the predisposing risk factors and degree of 
calcification of IAS support the current hypothesis on the delayed development of intracranial 
atherosclerosis.  
In the current study the association of IAS with the ESR was investigated as a marker of inflammatory 
processes in the atherosclerosis of the intracranial arteries. However, the ESR is only an indirect 
indicator of inflammatory processes and could be increased due to co-morbidity. We did not exclude 
patients with co-morbidity associated with ESR elevation to avoid additional bias. Evaluation of 
additional inflammatory markers such as high-sensitivity C-reactive protein and interleukins could 
have provided additional data on the role of inflammatory processes in intracranial atherosclerosis. 
Finally, the ESR was only measured at a single time point and during acute phase in part of the 
patients.  
 
Conclusion and Implications 
It has been suggested that atherosclerosis in the extracranial carotid artery is the primary source of 
ischemic stroke in Caucasian patients.38 Indeed, we observed a low prevalence of IAS in the current 
study population of predominantly Caucasian ethnicity. However, most IAS were observed in the 
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posterior circulation, a location associated with a high risk of recurrent stroke.1,28,29 Mainly non-
calcified IAS lesions were observed in distal intracranial arteries. A strong association of LDL 
cholesterol as well as ESR was identified with the presence of IAS, and more importantly with the 
presence of non-calcified IAS lesions, in patients with a recent TIA or ischemic stroke. Accordingly, 
in the intracranial atherogenesis a prominent role is indicated for inflammation. Further research on 
non-invasive analysis of plaque components in IAS lesions could improve understanding of the 
pathophysiology of intracranial atherosclerosis. The additional evaluation of intraplaque hemorrhage 
using high-resolution magnetic resonance imaging, which is likely to convey strong prognostic value 
for recurrent stroke, may be of particular interest.39  
 
Addendum 
Subsequent to publication of this paper in Stroke (x-x-2010) we discovered that 5 patients were 
wrongly identified as having symptomatic IAS during reanalysis for chapter 3.2. Specifically, 54 
instead of 59 patients with symptomatic IAS. Recalculation with the correct number of symptomatic 
patients did not change the significance of the outcomes. Results of the recalculation are illustrated 
in the Table 4. 
 
Corrected version of Table 4. Multivariable analysis of risk factors associated with exclusively non-calcified IAS lesions, 
calcified IAS lesions and symptomatic IAS.  
 
OR (95% CI)  
Non-calcified IAS 
lesions (n=126; 16%) 
OR (95% CI) 
Calcified IAS 
lesions (n=52; 7%) 
OR (95% CI)  
Symptomatic IAS 
(n=54; 7%) 
Age (per 10 years)* 1.37 (1.15-1.63) 2.09 (1.56-2.82) 1.38 (1.08-1.78) 
Male sex 1.56 (1.01-2.40) 1.29 (0.68-2.45) 1.62 (0.87-3.03) 
Asian ethnicity 2.02 (0.88-4.62) 2.52 (0.76-8.36) 3.57 (1.40-9.06) 
Hypertension 1.74 (1.02-2.96) 1.84 (0.79-4.31) 2.79 (1.13-6.90) 
Diabetes mellitus 2.13 (1.32-3.42) 1.37 (0.67-2.81) 1.21 (0.61-2.39) 
LDL cholesterol (mmol/l)* 1.29 (1.07-1.57) 1.25 (0.94-1.67) 1.11 (0.84-1.46) 
ESR (per 10mm/h)* 1.20 (1.05-1.37) 1.09 (0.88-1.35) 1.24 (1.04-1.47) 
*Ratio-per-unit increase. CI = confidence interval; OR = odds ratio. 
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Chapter 3.2   
 
Intracranial Atherosclerotic Stenosis assessed 
with Multidetector CT Angiography in TIA and 
Ischemic Stroke Patients is associated with 
increased risk of Ischemic Stroke 
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This thesis aims to improve understanding of atherosclerotic carotid plaque ulcerations as a 
source of artery-to-artery thromboembolism in patients with TIA and ischemic stroke. 
Furthermore, the prevalence of intracranial arterial stenosis (IAS) in patients with TIA or 
ischemic stroke was determined and the risk of recurrent ischemic stroke was assessed in 
patients with both symptomatic and asymptomatic IAS.  
 
The thesis has six objectives: 
I. To describe the frequency and location of plaque irregularities in patients with TIA or ischemic 
stroke, and the relationship of plaque irregularities with stenosis severity, cardiovascular risk 
factors and symptomatology. 
II. To test the hypothesis whether carotid plaque ulceration is more associated with non-lacunar 
stroke than with lacunar stroke. 
III. To analyze the relation between atherosclerotic carotid plaques ulceration and plaque 
volume, degree of stenosis, and plaque components in both patients with ≥50% stenosis as 
well as patients with a low degree stenosis (0-49%).  
IV. To explore the natural history of ulcerated plaques and to assess whether plaque 
ulcerations heal by studying the temporal changes in plaque surface morphology on serial 
imaging in patients with TIA or minor ischemic stroke. 
V. To investigate the prevalence, distribution and the calcification of IAS in a mainly European 
population of TIA and ischemic stroke patients. 
VI. To assess the occurrence of new ischemic strokes in patients with symptomatic and 
asymptomatic IAS as well as without IAS during long term follow-up. 
 




Carotid artery atherosclerotic plaque ulceration 
Chapter 2.1 describes the associations between carotid artery atherosclerotic plaques surface 
morphology assessed with MDCTA and severity of stenosis, cardiovascular risk factors, and 
type of ischemic cerebrovascular symptoms in patients with TIA or ischemic stroke. The 
presence of ulcerated or irregular plaques in the carotid artery was strongly related with the 
severity of stenosis, and ulcerations were more often present in severe stenotic carotid 
arteries. However, ulcerations were also present in 9% of carotid arteries with a stenosis of 
less than 30%. Ulcerations were predominantly located proximal to the site with the severest 
stenosis. This finding supports the hypothesis that shear stress plays a crucial role in the 
development of vulnerable plaque and plaque rupture. Complicated plaque surfaces were 
more frequently present in symptomatic carotid arteries compared to asymptomatic carotid 
arteries. However, this finding can be entirely attributed to the significantly higher degree of 
stenosis in the symptomatic arteries. Analysis of stroke symptoms revealed a lower frequency 
of complicated plaques among patients with amaurosis fugax compared to patients with 
cerebral ischemic events. Hypercholesterolemia was independently related to the presence of 
complicated plaques.  
Carotid plaque ulceration is a marker of previous plaque rupture and may lead to subsequent 
thromboembolism in large intracranial arteries leading to deep or cortical infarcts. To test this 
hypothesis, we examined the association between atherosclerotic plaque ulceration with non-
lacunar ischemic stroke compared to lacunar stroke in Chapter 2.2. This study revealed that 
atherosclerotic carotid plaque ulceration is associated with non-lacunar ischemic stroke, 
independent of the degree of carotid stenosis. These results suggest that non-lacunar stroke 
and lacunar stroke are indeed caused by different pathophysiological mechanisms. 
Carotid plaque ulceration has been associated with the presence of fibrous cap rupture and 
distinct plaque components such as intraplaque hemorrhage, large lipid core, and less fibrous 
tissue in patients with severe symptomatic stenosis.1 However, whereas a ≥50% carotid 
stenosis is present in only approximately 10% of patients with cerebral ischemic events, 
histological and non-invasive imaging studies assessing the relation of carotid plaque 
characteristics with plaque surface disruption have been limited to these patients with a ≥50% 
carotid stenosis.1-3 In Chapter 2.1 we demonstrated that plaque ulcerations are also present in 
carotid atherosclerosis with a stenosis <50%, which suggests that plaque composition could 
also play a role in plaque rupture of small plaques. Limited data are available on the association 
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between plaque volume and carotid plaque surface disruption.3 This association is relevant as 
larger plaques may be more prone to ulceration. In addition, adjustment for plaque volume is 
needed when evaluating the association between plaque composition and plaque ulceration. 
In Chapter 2.3 therefore we evaluated the relation between carotid artery atherosclerotic 
plaques ulceration and plaque volume, and plaque components as assessed with MDCTA in 
patients with ≥50% stenosis as well as in those with a lower degree stenosis of 0-49%. Plaque 
volume and LR-NC proportion, evaluated noninvasively with MDCTA, were associated with 
plaque ulceration in the carotid artery in both patients with ≥50% and <50% stenosis. This 
association between the LR-NC proportion and carotid plaque ulceration was independent of 
the degree of stenosis or plaque volume. Plaque composition analysis with MDCTA may prove 
useful for detection of rupture-prone plaques and could potentially improve risk stratification in 
ischemic stroke patients. 
Carotid plaque ulcerations are considered to result from rupture of thin fibrous caps of 
atherosclerotic plaques. Persisting carotid plaque ulcerations may be an additional cause of 
thrombo-embolic stroke due to local flow disturbances.4-6 Current knowledge on the evolution 
of atherosclerotic plaque rupture is primarily based on histological analysis of coronary arteries 
in autopsy studies or specimens obtained from carotid endarterectomies.7-11 To explore the 
natural history of ulcerated plaques and to assess whether plaque ulcerations heal, we studied 
the temporal changes in plaque surface morphology on serial MDCTA in patients with TIA or 
minor ischemic stroke in Chapter 2.4. Plaque surface morphology remained unchanged in a 
large majority of arteries, whereas in a small minority of arteries new irregularities and 
ulceration occurred or existing irregularities or ulceration disappeared. Carotid plaque 
ulcerations may therefore persist for a long time and may not represent a recent plaque 
rupture. These persisting carotid ulcerations may remain a potential source of thrombo-
embolism as a result of focal turbulence.  
 
Intracranial arterial stenotic lesions  
It is presumed that symptomatic IAS accounts for around 8–10% of all ischemic strokes.12,13 
More insight into the prevalence, distribution and calcification of IAS lesions could help identify 
high risk patients requiring more aggressive secondary prevention and improve effectiveness 
of therapies. In Chapter 3.1 we evaluated a large cohort of patients with TIA or ischemic stroke 
for the prevalence, distribution and the calcification of IAS lesions using MDCTA. Furthermore, 
the association of IAS with the traditional risk factors for cerebrovascular disease as well as 
with ESR was investigated. IAS lesions were present in 23% of patients. Most stenoses were 
located in the arteries of the posterior circulation, which are associated with a high risk of 
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recurrent stroke.14-16 IAS lesions in the basilar artery and arteries beyond the circle of Willis 
were mainly non-calcified. In addition to age, sex and several traditional cerebrovascular risk 
factors, ESR was independently associated with the presence of IAS and with the presence of 
non-calcified IAS in particular. This may indicate a prominent role for inflammation in 
intracranial atherogenesis.  
Recurrence rates of 10% to 14% per year have been reported in patients with previously 
symptomatic IAS.14,15,17,18 In Chapter 3.2 we evaluated the occurrence of new ischemic strokes 
in patients with symptomatic and asymptomatic IAS as well as without IAS during long term 
follow-up. We observed a significantly increased ischemic stroke rate in patients with 
symptomatic IAS compared to patients without IAS. No increase in ischemic stroke rate was 
observed in patients with asymptomatic IAS. This study found a high risk of recurrent ischemic 
stroke in patients with symptomatic IAS, which is more than doubled compared to patients 
without IAS. This provides arguments for continued research efforts towards targeted 




Carotid artery atherosclerotic plaque ulceration 
Pathophysiological mechanisms of cerebrovascular disease have been studied extensively. 
However, the nature of both transient as well as lasting ischemic cerebral symptoms remains 
unexplained in between 30 percent and 40 percent of ischemic strokes. Several mechanisms 
have been suggested for these so-called cryptogenic strokes, including occult paroxysmal 
atrial fibrillation, patent foramen ovale, aortic arch atherosclerosis, atrial cardiopathy, and 
substenotic atherosclerosis of the vertebrobasilar and extracranial carotid arteries.19  
Artery-to-artery embolism is assumed to be an important pathophysiological mechanism in 
transient ischemic attacks (TIAs) or ischemic stroke ipsilateral to atherosclerotic plaques. 
Traditionally, two theories have been proposed to explain artery-to-artery embolism. The first 
is a hemodynamic concept which states that a high-grade stenosis produces symptoms by 
reduced and turbulent blood flow. The second theory explains ischemic cerebral symptoms as 
the result of cerebral emboli originating from irregular arteriosclerotic plaques frequently 
Iocated in the extracranial arteries, principally in the common carotid artery bifurcation.20-23 
Since plaque irregularities are often present in atherosclerotic disease without stenosis greater 
than 50%, the conventional definitions relating ischemic stroke to a specific etiology must be 
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disputed, as large artery atherosclerosis is currently only considered the etiology of ischemic 
stroke in patients with carotid artery stenosis of more than 50%.  
The clinical significance of ulcerated carotid plaques is supported by numerous studies. Strong 
associations have been found between plaque ulceration and downstream cerebral 
microemboli measured preoperatively with Transcranial Doppler (TCD).5,24,25 Presence of 
ulcerations is a risk factor for ischemic stroke.26-29 It increases the risk for neurologic symptoms 
by approximately four times.30 Although the risk for ischemic stroke related to ulcerated carotid 
plaques increases with more severe stenosis, also ulceration of plaques with low-grade 
stenosis of ≤50% have been correlated with ischemic cerebral symptoms.28,31  
In Chapter 2.1 we demonstrated that although irregular or ulcerated plaques are more common 
in carotid arteries with stenosis of >50%, they are also present carotid arteries with stenosis of 
<50%. Furthermore, the study found that complicated plaques are more often present in the 
symptomatic carotid arteries than in the contralateral asymptomatic carotid artery, but this was 
fully attributed to a significantly higher degree of stenosis in the symptomatic arteries. These 
findings suggest that carotid artery plaque irregularities may be a cause of cryptogenic stroke 
in patients who do not fulfill the criteria of large artery atherosclerosis according to the TOAST 
classification.  
In Chapter 2.2 we demonstrated that carotid plaque ulcerations are indeed associated with 
non-lacunar ischemic strokes, which is confirmed by later reports.32 This suggests that 
ulcerations are not just a marker of increased risk, but part of the pathophysiological cascade 
linking atherosclerotic disease to ischemic cerebral symptoms. For this reason, unstable and 
ulcerated plaques could be an important target for therapies to prevent (re-)ulceration. 
Although superficial irregularity of plaque surfaces without a clear ulceration have also been 
associated with an increased stroke risk,23,27,33,34 these findings were not confirmed in a recent 
meta-analysis for US-detected plaque irregularities.30  
Since ulcerations are related to ischemic stroke, the question arises of what causes plaque 
ulceration. Ulceration of atherosclerotic plaque is considered to be a remnant of plaque rupture 
which is related to a specific plaque components like intraplaque hemorrhage, large lipid core, 
and less fibrous tissue.35 The study in Chapter 2.3 reveals that plaque volume, degree of 
stenosis, and LR-NC proportion evaluated non-invasively with MDCTA are associated with 
carotid artery plaque ulceration, even in patients with a low degree stenosis (0-49%). In this 
study calcification volume as a proportion of the total plaque volume was inversely associated 
with plaque ulceration. A recent study, however, reported that surface and multiple 
calcifications and ulceration associated with intra-plaque hemorrhage in the carotid artery, 
which can lead to rupture of the plaque surface.36 The latter study was performed with MRI, 
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which is an imaging modality that in contrast to CT is able to depict intraplaque hemorrhage. 
Our findings are supported by a recent systematic review and meta-analysis which reported 
that soft plaque and plaque ulceration on CTA are associated with ipsilateral cerebrovascular 
ischemia, while calcified plaque is negatively associated with downstream ischemic events.37 
Our study, which found that in addition to stenosis measurement, plaque volume and 
composition analysis with MDCTA may identify rupture prone vulnerable plaques, 
demonstrates that risk stratification in ischemic stroke patients could be improved with non-
invasive imaging of atherosclerotic plaque features. 
After plaque rupture, healing of the affected plaque may occur. A basis of a disrupted fibrous 
cap with an overlying repair response is observed in pathological examination of coronary 
artery specimens.38 Although rupture healing may reduce the risk of thromboembolic ischemic 
stroke, repeated rupture healing increases plaque volume and degree of luminal stenosis in 
coronary arteries. Our study in Chapter 2.4 on plaque evolution in carotid arteries with serial 
MDCTA in patients with TIA or minor ischemic stroke revealed that plaque surface morphology 
remains unchanged in a large majority of arteries. These results are in line with a prospective 
3D ultrasound study which reported that the vast majority of plaques (76.5%) remained 
unchanged for more than a year, 23.5% of ulcerations regressed while only 5.8% of ulcerations 
progressed.39 We therefore conclude that these persisting carotid artery plaque ulcerations 
may remain a potential source of new thrombo-embolism.  
 
Intracranial arterial stenotic lesions  
Several studies have elucidated the therapeutic management of IAS. Two main therapeutic 
strategies are available: revascularization combined with medical management or only medical 
management. Several trials have demonstrated the feasibility of revascularization through 
endovascular stenting.40-42 However, two more recent randomized trials compared stenting 
combined with medical management to medical management alone in patients with 
symptomatic IAS.43,44 Stenting was associated with an increased risk of TIA, stroke, death, or 
intracranial hemorrhage and showed no benefit in any subpopulation of patients. Patients 
already enrolled in the SAMMPRIS trial continued to be followed for a median of 32.4 months, 
during which 15% of those randomized to the medical management group and 23% of the 
stenting group had a primary endpoint.43 Aggressive medical management in the control arm 
of the SAMPRISS trial resulted in a stroke risk comparable to that in similar patients in the 
WASID trial after adjustment of confounding characteristics. The authors concluded that the 
early benefit of aggressive medical management over stenting for high-risk patients with IAS 
persists during extended follow-up. Like the SAMMRPIS trial, the VISSIT trial showed a lower 
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than expected rate of stroke in the medical group and high procedural complication rates in 
the stent group.44 The findings of these trials lend support to the use of aggressive medical 
management rather than stenting in high-risk patients with IAS. 
 
Methodological considerations  
 
The studies in this thesis were conducted in a cohort of consecutive TIA and stroke patients to 
investigate the associations between atherosclerotic plaque characteristics and ischemic 
symptoms. The studies aim to elucidate the pathophysiology relating atherosclerotic plaque 
development to ischemic stroke, to intervene in this process, and thereby prevent future 
ischemic strokes. However, all but one of the studies had a cross-sectional design, allowing 
for associations to be studied. In order to determine the precise importance of the findings in 
these cross-sectional studies, the value of image-based plaque characteristics for risk 
prediction should be confirmed in prospective studies. 
The patient-based approach in this thesis differs from a population health approach, which 
aims to decrease the incidence of (primary) strokes through preventive measures in the 
general population. Longitudinal population-based studies could increase knowledge about 
atherosclerotic plaque progression and help improve risk stratification. Similarly, analysis of 
patient cohort studies could provide detailed estimates of recurrence risk based on clinical and 
imaging characteristics.  
The applied stroke subtype classification in Chapter 2.2 was based on clinical symptoms and 
corrected for relevant infarctions seen on brain CT. Although a clinical approach results in an 
accurate classification in most patients, some misclassifications are inevitable. Nonetheless, 
after replicating the analysis based on CT brain infarctions alone as a substitute for clinically 
defined stroke subtypes, the association between carotid plaque ulceration and non-lacunar 
infarction remained.  
Although MDCTA has been shown to be an excellent technique to evaluate carotid 
ulceration,45,46 a limitation of our studies on ulceration is the absence of conformation of the 
findings through histologic specimens. The correlation with histological results is troublesome 
because only patients with a severe stenosis (NASCET >70% stenosis) are eligible for surgical 
intervention. Furthermore, even in patients with >70% carotid artery stenosis histology was not 
always obtained, as stenting was performed in a large proportion of the patients in our cohort. 
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Fibrous cap thickness and rupture which are both related to atherosclerotic plaque instability 
cannot be reliably detected with MDCTA. The presence of intraplaque hemorrhage was not 
evaluated as the plaque composition analysis software used in Chapter 2.3 has not been 
validated for differentiation of intraplaque hemorrhage. As a result, both LR-NC and fibrous 
tissue assessed with MDCTA may contain intraplaque hemorrhage. Furthermore, with the 
need of intravenous contrast material and ionizing radiation, MDCTA is not entirely non-
invasive nor harmless.47,48 
All patients in the study cohort received secondary preventive therapies including antiplatelet 
therapy and management of vascular risk factors. A recent systematic review and meta-
analysis of studies using virtual histology on intravascular ultrasound found a significant effect 
of statin therapy on plaque and external elastic membrane volumes as well as fibrous and 
calcium volumes, whereas no effect was found on lumen volume, fibro-fatty and necrotic tissue 
volumes.49 Secondary preventive therapies, particularly improved blood pressure control and 
antiplatelet therapy have contributed to a substantial decline in recurrent stroke and vascular 
event rates over the last 5 decades.50 These therapies may have influenced outcomes in 
several studies in this thesis such as the development of extracranial carotid artery plaques in 
Chapter 2.4 or the stroke recurrence risk in Chapter 3.2. However, we studied associations of 
clinical and imaging parameters with recurrence risk and plaque evolution in terms of relative 
risk, adjusted for confounders, which minimizes this bias. 
 
Future directions  
 
In recent years, MDCTA has emerged as an efficient medical imaging modality in acute stroke 
care. The Dutch guideline for stroke care recommends evaluating the cerebral arterial 
circulation from the aortic arch to the intracranial arteries with MDCTA to determine the 
presence and location of an arterial occlusion. This recommendation applies to all patients who 
may be eligible for intra-arterial treatment, i.e. with a clinical diagnosis of cerebral infarction 
without an intracranial hemorrhage on non-contrast cranial CT and without contraindications 
for intra-arterial thrombolysis (IAT). In addition to MDCTA, duplex ultrasonography or contrast 
MRA is recommended to detect carotid stenosis, replacing DSA as pre-intervention imaging.  
This leading role of MDCTA in acute stroke care could be used to further investigate the role 
of CT imaging biomarkers such as plaque composition or ulcerations in the pathophysiology 
of thrombo-embolic stroke. Given the persistent presence of plaque ulceration found in this 
 
- 132 - 
 
thesis, their role in the pathogenesis of ischemic stroke and therapeutic management should 
be further explored in longitudinal studies.  
The risk of recurrent ischemic stroke in patients with symptomatic IAS is high, and it is more 
than doubled compared to patients without IAS. This provides arguments for continued 
research efforts into focused therapeutic strategies, and also for intensive preventive treatment 
of these patients. Further research on non-invasive analysis of plaque components in IAS 
lesions could improve understanding of the pathophysiology of intracranial atherosclerosis. 
The additional evaluation of intraplaque hemorrhage using high-resolution magnetic 
resonance imaging, which is likely to convey strong prognostic value for recurrent stroke, may 
be of interest. 
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The general introduction (Chapter 1) of this thesis first outlines the relationship of both 
extracranial carotid artery and intracranial large artery atherosclerotic plaque characteristics 
with cerebral ischemic events. The concepts of atherosclerotic plaque vulnerability and healing 
of plaque rupture are described. The potential of different imaging techniques to assess 
atherosclerotic plaque characteristics is discussed. Finally, the objective and research 
questions of the thesis are explained. 
 
Carotid artery atherosclerotic plaque ulceration 
The studies in Chapter 2 of the thesis focus on improving insight in carotid artery 
atherosclerotic plaque ulcerations as assessed with MDCTA, and the role of these ulcerations 
in TIA or ischemic stroke. Chapter 2.1 describes the associations between carotid artery 
atherosclerotic plaques surface morphology assessed with MDCTA and severity of stenosis, 
cardiovascular risk factors, and type of ischemic cerebrovascular symptoms in patients with 
TIA or ischemic stroke. The presence of ulcerated or irregular plaques in the carotid artery was 
strongly related with the severity of stenosis. Ulcerations were predominantly located proximal 
to the site with the severest stenosis. Complicated plaque surfaces were more frequently 
present in symptomatic carotid arteries compared to asymptomatic carotid arteries, what can 
be fully attributed to the significantly higher degree of stenosis in the symptomatic arteries. A 
lower frequency of complicated plaques was present among patients with amaurosis fugax 
compared to patients with cerebral ischemic events. Hypercholesterolemia was independently 
related to the presence of complicated plaques. In Chapter 2.2 the association of 
atherosclerotic plaque ulceration with non-lacunar stroke as compared to lacunar stroke was 
examined in patients with TIA or ischemic stroke. Atherosclerotic carotid plaque ulceration is 
associated with non-lacunar ischemic stroke, independent of the degree of carotid stenosis. In 
Chapter 2.3 we evaluated the relation between carotid artery atherosclerotic plaques ulceration 
and plaque volume, degree of stenosis, and plaque components as assessed with MDCTA in 
both patients with ≥50% stenosis as well as in those with a low degree stenosis of 0-49%. 
Plaque volume, degree of stenosis, and lipid-rich necrotic core (LR-NC) proportion evaluated 
non-invasively with MDCTA were associated with carotid artery plaque ulceration, also in 
patients with a low degree stenosis (0-49%). This association between the LR-NC proportion 
and carotid plaque ulceration was independent of the degree of stenosis. In Chapter 2.4 we 
assessed the temporal changes in plaque surface morphology on serial MDCTA in patients 
with TIA or minor ischemic stroke. Plaque surface morphology remained unchanged in a large 
majority (88%) of arteries, whereas in a small minority of arteries new irregularities and 
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ulcerations occurred (8%) or existing irregularities or ulcerations disappeared (4%). Plaque 
morphology remained unchanged in most ulcerated plaques (67%). 
 
Intracranial arterial stenotic lesions  
Chapter 3 of this thesis describes the prevalence, distribution and morphology of IAS in 
patients with TIA and ischemic stroke patients. Furthermore, the occurrence of new ischemic 
strokes in patients with symptomatic and asymptomatic IAS was evaluated during long term 
follow-up. In Chapter 3.1 we evaluated a large cohort of patients with TIA or ischemic stroke 
for the prevalence, distribution and the calcification of IAS lesions using MDCTA. Furthermore, 
the association of IAS with the risk factors for cerebrovascular disease as well as with ESR 
was investigated. IAS were present in 23% of patients. Most stenoses were located in the 
posterior circulation arteries. IAS in the basilar artery and arteries beyond the circle of Willis 
were mainly non-calcified. In addition to age, gender and several traditional cerebrovascular 
risk factors, ESR was independently associated with the presence of IAS and with the 
presence of non-calcified IAS in particular. In Chapter 3.2 we evaluated the occurrence of new 
ischemic strokes in patients with symptomatic and asymptomatic IAS as well as without IAS 
during long term follow-up. A significantly increased ischemic stroke rate was observed in 
patients with symptomatic IAS compared to patients without IAS. No increase in ischemic 
stroke rate was observed in patients with asymptomatic IAS.  
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De algemene inleiding (hoofdstuk 1) van dit proefschrift beschrijft de relaties tussen 
kenmerken van atherosclerotische plaques in zowel de extracraniële halsslagaders als de 
intracraniële slagaders met herseninfarcten en transient ischemic attacks (TIA’s). De 
eigenschappen van de kwetsbare, instabiele atherosclerotische plaques en van genezing van 
atherosclerotische plaques na een plaqueruptuur worden beschreven. Na een ruptuur van een 
atherosclerotische plaque kan een holte in de plaque achterblijven met open verbinding naar 
het bloedvat lumen. Deze holtes worden ook wel ulceraties genoemd. De mogelijkheden om 
met verschillende beeldvormingstechnieken eigenschappen van atherosclerotische plaques te 
bestuderen worden besproken. Ten slotte worden de doelen en de onderzoeksvragen van het 
proefschrift beschreven. 
 
Atherosclerotische plaque ulceratie van de halsslagader 
Hoofdstuk 2 van het proefschrift richt zich op de associaties tussen atherosclerotische plaque 
ulceratie van de halsslagader en de ernst van stenose, cardiovasculaire risicofactoren, 
plaquevolume en -samenstelling, evenals herseninfarct subtypen. Hoofdstuk 2.1 beschrijft de 
associaties tussen de oppervlakmorfologie van atherosclerotische plaques van de 
halsslagader beoordeeld met multidetector computed tomography angiography (MDCTA), en 
ernst van stenose (bloedvatvernauwing), cardiovasculaire risicofactoren en type ischemische 
cerebrovasculaire symptomen bij patiënten met een herseninfarct of TIA. De 
oppervlakmorfologie van atherosclerotische plaques van de halsslagader werd geclassificeerd 
als geulcereerd, onregelmatig of glad. Plaques met een geulcereerd of onregelmatig oppervlak 
werden samengevoegd geanalyseerd als gecompliceerde plaques. De aanwezigheid van 
plaque ulceraties of onregelmatige plaques in de halsslagader was sterk gerelateerd aan de 
ernst van stenose. Plaque ulceraties waren voornamelijk gesitueerd proximaal van het punt 
van de sterkste vernauwing van de halsslagader. Gecompliceerde oppervlakmorfologie was 
vaker aanwezig in symptomatische halsslagaders in vergelijking met asymptomatische 
halsslagaders. Dit kan volledig worden toegeschreven aan de significant hogere stenosegraad 
in de symptomatische halsslagaders. Gecompliceerde plaques waren minder vaak aanwezig 
bij patiënten met amaurosis fugax in vergelijking met patiënten met cerebrale ischemie. 
Hypercholesterolemie was onafhankelijk gerelateerd aan de aanwezigheid van 
gecompliceerde plaques. In hoofdstuk 2.2 werden de associaties tussen atherosclerotische 
plaque ulceraties, niet-lacunaire herseninfarcten en lacunaire herseninfarcten vergeleken. 
Atherosclerotische plaque ulceraties van de halsslagader waren geassocieerd met niet-
lacunaire herseninfarcten, onafhankelijk van de mate van vernauwing van de halsslagader. In 
hoofdstuk 2.3 evalueerden we de relatie tussen ulceraties, plaque volume en plaque 
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compositie van atherosclerotische plaques in de halsslagader door middel van MDCTA bij 
zowel patiënten met ≥50% stenose als bij patiënten met een lage stenosegraad van 0-49%. 
Plaque volume, stenosegraad en lipid-rich necrotic core (LR-NC) percentage waren 
geassocieerd met plaque ulceratie, ook bij patiënten met een lage mate stenosegraad van 0-
49%. Deze associatie tussen de LR-NC-percentage en plaque ulceratie was onafhankelijk van 
de mate van vernauwing van de halsslagader. In hoofdstuk 2.4 hebben we de veranderingen 
in de tijd van oppervlaktemorfologie van atherosclerotische plaques in halsslagaders 
onderzocht met behulp van seriële MDCTA bij patiënten met TIA of een herseninfarct. De 
morfologie van het plaque-oppervlak bleef ongewijzigd in een grote meerderheid van de 
slagaders (88%). In een kleine minderheid van de slagaders ontstonden nieuwe ulceraties of 
onregelmatigheden (8%), of verdwenen bestaande ulceraties of onregelmatigheden (4%). De 
morfologie van geulcereerde atherosclerotische plaques bleef in 67% onveranderd. 
 
Stenotische laesies van intracraniële arteriën  
Hoofdstuk 3 van dit proefschrift beschrijft de prevalentie, distributie en morfologie van 
intracraniële atherosclerotische stenosen (IAS) bij patiënten met een herseninfarct of TIA. 
Daarnaast wordt het optreden van nieuwe herseninfarcten bij patiënten met symptomatische 
en asymptomatische IAS tijdens langdurige follow-up beschreven. In hoofdstuk 3.1 
evalueerden we patiënten met een herseninfarct of TIA voor de prevalentie, distributie en 
verkalking van IAS laesies met behulp van MDCTA. Verder werd de associatie van IAS met 
de cerebrovasculaire risicofactoren en met bezinking (ESR) onderzocht. IAS was aanwezig bij 
23% van de patiënten. De meeste stenosen bevonden zich in het stroomgebied van de 
achterste intracraniële slagaders. IAS in de arteria basilaris en slagaders distaal van de cirkel 
van Willis waren hoofdzakelijk niet-verkalkt. Naast leeftijd, geslacht en verschillende 
cerebrovasculaire risicofactoren, was bezinking onafhankelijk geassocieerd met de 
aanwezigheid van IAS en met de aanwezigheid van niet-verkalkte IAS in het bijzonder. In 
hoofdstuk 3.2 evalueerden we het optreden van nieuwe herseninfarcten bij patiënten met 
symptomatische IAS, asymptomatische IAS en patiënten zonder IAS tijdens langdurige follow-
up. Een significant verhoogd aantal herseninfarcten werd waargenomen bij patiënten met 
symptomatische IAS in vergelijking met patiënten zonder IAS. Er werd geen toename van de 
herseninfarcten waargenomen bij patiënten met asymptomatische IAS. 
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